Skip to main content
Register
Conference App
Schedule
Full Schedule
Browse by Track
Browse by Session Type
Browse by Speakers
Keyword Search
Browse by Poster Abstract
Browse by Poster Number
Browse by Poster Title
Browse by Presenter
Browse by Track
Browse by SubTrack
Solution Center
Floorplan
Browse by Company
Browse by Booth Number
Browse by Track
Networking Activities
Community Event
Healthy Start
Philanthropy
Reception
Affiliate Event
Sponsors
Attendees
Login required
My Schedule
Login required
Login
Toggle navigation
Home
Register
Conference App
Schedule
Full Schedule
Browse by Track
Browse by Session Type
Browse by Speakers
Keyword Search
Browse by Poster Abstract
Browse by Poster Number
Browse by Poster Title
Browse by Presenter
Browse by Track
Browse by SubTrack
Solution Center
Floorplan
Browse by Company
Browse by Booth Number
Browse by Track
Networking Activities
Community Event
Healthy Start
Philanthropy
Reception
Affiliate Event
Sponsors
Attendees
Login required
My Schedule
Login required
Schedule at-a-Glance
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Preclinical Development
Bioanalytics
Clinical Pharmacology
Manufacturing and
Bioprocessing
Formulation and Quality
Rapid Fire Preclinical
Rapid Fire Bioanalytics
Rapid Fire Clinical
Pharmacology
Rapid Fire Manufacturing &
Bioprocessing
Rapid Fire Formulation
Career Development
Networking Events
Partner Presentation-
Preclinical
Partner Presentation-
Bioanalytics
Partner Presentation-
Clinical Pharmacology
Partner Presentation-
Formulation
Software Lab
Tech Challenge
Home
Browse by Track
Browse by Track
Browse by Track
Type here to filter the list
Bioanalytics
W1230-12-79 - A Faster Method for Relative Quantification of N-glycans for Therapeutic Monoclonal Antibody during Trastuzumab Biosimilar Development
Favorite
M1530-11-72 - A Fully Validated LC-MS/MS Method for Quantitation of Oxybenzone in Serum
Favorite
T1030-11-71 - A Novel Blood-Based Biomarker Distinguishes Estrogen-Negative Solid Tumors in Patient Samples
Favorite
W1030-11-72 - A Robust and Specific LC-MS/MS Method for the Measurement of Cortisol as a Biomarker in Human Serum for Clinical Studies
Favorite
M0930-11-71 - A Sensitive and Selective UPLC-MS/MS Method for Simultaneous Determination of Paclitaxel, Gemcitabine, and Carboplatin in Human Plasma and Animal Tissues
Favorite
T1230-11-73 - A Sensitive ELISA Method for the Quantification of Anti-PD-1 Antibody Drug in Human Serum
Favorite
M1530-11-73 - A Sensitive Quantification of Unbound Vemurafenib in Human Plasma Using Equilibrium Dialysis Followed By Ultra-performance Liquid Chromatography Coupled to a Tandem Mass Spectrometry
Favorite
M0930-12-78 - Activatable Core–Shell Metallofullerene Nanoprobes for High Relaxivity Magnetic Resonance/Fluorescence Bimodal Imaging of Glutathione
Favorite
M1430-11-76 - Assay Acceptance and Reporting Criteria of the Dendritic Cell Activation Assay Contributing to the Assessment of Innate Immunogenicity Risk
Favorite
T1230-12-80 - Assay and Identification of a Growth Media Containing 4 Amino Acids by a Novel HPLC Method with Charged Aerosol Detection
Favorite
W0930-12-78 - Assay Development Kit - Rapid Reagent Pair Screening and Optimization for Ligand-Binding Assays
Favorite
T1330-11-73 - Assay Performance Evaluation of Simple Plex
TM
Cartridge-Based ELLA and DuoSet ELISA Assay for the Detection of B-cell Maturation Antigen (BCMA) Biomarker
Favorite
W0930-11-71 - Assessment of Chemical Reactivity of BTK Covalent Inhibitors by a Simple Reaction Assay with GSH
Favorite
T1130-11-73 - Assessment of Pre-Existing Anti-Drug Antibodies Against Novel Nanobody Therapeutic
Favorite
M1330-12-77 - Bioanalytical and Logistical Considerations in Patient Centric Volumetric Absorptive Microsampling
Favorite
W1130-11-71 - Biodistribution of TAT or QLPVM Coupled to Receptor Targeted Liposomes for Delivery of Anticancer Therapeutics to Brain In Vitro and In Vivo
Favorite
T1430-11-73 - Bullfrog oil (Rana catesbeiana Shaw) Induces Apoptosis in A2058 Human Melanoma Cells by Mitochondrial Dysfunction Triggered by Oxidative Stress
Favorite
T1130-12-80 - Cancer Stem Cells and Tyrosine Kinase Receptors Directed Non-Lipid Based Nanoparticles for Pancreatic Ductal Adenocarcinoma Imaging and Therapy
Favorite
W1230-12-77 - Capillary Microsampling Combined with a Microfluidic Immunoassay Technology Provides a Reliable and Robust Method to Measure Therapeutic Antibodies and Their Targets in Preclinical Studies
Favorite
T1130-11-74 - Case Study to Demonstrate Sensitivity in Immunogenicity Assay Should be Based on Result of Both Screening and Confirmatory Tier
Favorite
M1330-11-71 - Cell Wall Metabolite Levels in
S. aureus
as a Function of Growth Phase
Favorite
T1030-12-80 - Characterization of a Cysteine-conjugated ADC on a Hybrid Quadrupole-Orbitrap Mass Spectrometer
Favorite
T1230-12-81 - Confident and Efficient Characterization of Recombinant Human Follicle Stimulating Hormone with the Q Exactive HF-X BioPharma Platform
Favorite
M1030-12-79 - CTLA4 Immunoassay Validation and Application to Disease Sample Analysis
Favorite
W1130-11-72 - Detection of Dry-Eye Biomarkers in Pooled Human Tears Using Hydrogel-Coated Gold Nanoshells
Favorite
T0930-11-72 - Determination of Total and Free Melphalan Concentrations in Human Plasma Using LC-Tandem Mass Spectrometry
Favorite
T1530-11-74 - Determination of Unbound Piperaquine in Human Plasma
Favorite
T1530-12-77 - Development and Characterization of GLP-1 Total and Active V-PLEX
®
Assays
Favorite
T1030-11-72 - Development and Characterization of Human and Rodent Metabolic Assays on the U-PLEX® Platform
Favorite
M1230-11-71 - Development and Characterization of LDV-Peptide Targeted Nanocarriers for Paclitaxel Delivery: A Comparative Study of Micelles, Liposomes and Solid Lipid Nanoparticles
Favorite
M1030-12-77 - Development and Implementation of a Flow Cytometry Assay to Measure Receptor Occupancy of an Anti-CD73 Antibody to Target in a Clinical Trial
Favorite
W1030-11-71 - Development and Implementation of the S-PLEX
®
Platform for Converting Standard Immunoassays to High-Sensitivity Assays
Favorite
T1330-12-77 - Development and Validation of a Human Total Soluble TIM-3 Biomarker Assay for Use in Clinical Studies
Favorite
M0930-11-74 - Development and Validation of a LC-MS/MS Method for Simultaneous Measurement of Tanespimycin and Its Active Metabolite (17-AG) in Human Plasma
Favorite
T1430-12-80 - Development and Validation of a Liquid Chromatography Tandem Mass Spectrometry Method as per ICH Guidelines for Quantification of LXR Agonist GW3965 in Mouse Plasma
Favorite
W1130-12-79 - Development and Validation of a New LC-MS/MS Method for Measuring Transmucosal Delivery of Mycophenolate In Vivo
Favorite
T1530-11-71 - Development and Validation of a New LC-MS/MS Method for Measuring Transmucosal Delivery of Oxaliplatin In Vivo
Favorite
M1530-12-82 - Development and Validation of a Quantitative Method for Fulvestrant in Rat Plasma by LC-MS/MS
Favorite
M0930-11-73 - Development and Validation of a Sensitive UPLC-MS/MS Method for Simultaneous Determination of Polydatin and Resveratrol in Plasma: Application to Pharmacokinetic Study
Favorite
T1330-11-72 - Development and Validation of an LC-MS/MS Method for the Simultaneous Quantitation of Fifteen Bile Acids in Human Serum
Favorite
W1130-12-77 - Development and Validation of LC-MS/MS Methods for the Quantitation of Commonly Co-administered Drugs and in Support of Several Clinical Studies
Favorite
M1430-11-74 - Development of a Neutralizing Antibody Assay with Improved Drug Tolerance for an Investigational Antibody by Applying Drug Depletion to Serum Samples
Favorite
M1430-11-73 - Development of a Novel Cell-Based Assay for the Detection of Neutralizing Antibodies to PF-06730512
Favorite
W1030-12-78 - Development of a Novel U-PLEX Method to Differentiate Between Anti-drug Antibody and Target Signals
Favorite
M1530-12-78 - Development of a Sensitive LC-MS/MS-Based Method for the Simultaneous Use of Mannitol and Sucrose as Markers of Blood-Brain Barrier Integrity
Favorite
M1530-12-81 - Development of a Simple and Robust Tryptic Digestion Method for the Determination of Therapeutic Antibodies by LC/MS
Favorite
T1430-12-78 - Development of an Intestinal Tissue Bioanalytical Assay Method for Quantitation of an Antiviral Drug Active Metabolite (CMX521-PPP) and its use in a Pre-Clinical in vivo Analyte Localization Analysis
Favorite
W1130-12-78 - Development of Highly Sensitive (4 pg/mL LOQ) HPLC-MS/MS Bioanalytical Method to Support Clinical Studies of an Inhaled Compound
Favorite
M1330-11-73 - Distribution and Recovery of Human Neonatal Fc Receptor (FcRn) in Sucrose Gradient Fractions from Human Liver Tissues using Multiple Reaction Monitoring (MRM)-based Targeted Proteomic Methods
Favorite
M1330-12-79 - Driving Effectiveness of the Analytical Method Lifecycle with Ruggedness Studies
Favorite
W1230-11-72 - Drug Delivery Using Biocompatible Polymer Encapsulated Magnetic Nanocarriers (PE-MNCs) Enhances Neurite Outgrowth on Inhibitory Substrate
Favorite
T1130-12-79 - Dual Functionalized Liposomes for Efficient Co-delivery of Anti-cancer Chemotherapeutics for the Treatment of Glioblastoma
Favorite
W1130-12-80 - Effect of
Rumex acetosa
Extract on P-gp and OATP1A2
Favorite
M1030-11-74 - Effect of Freeze Thaw Cycles of Conjugated Reagents on Immunogenicity Assays
Favorite
M1330-11-76 - Effect of Vancomycin on Cytoplasmic Peptidoglycan Intermediate Levels in Vancomycin Resistant
Enterococci
Favorite
T1130-12-78 - Effective Formulation of Antioxidant Natural Compound to Polymeric Nanosuspension Shows Better Tumor Regression and Survival
Favorite
T1330-12-79 - Enantiomeric Purity Analysis for Solid Phase Synthesized Peptide Active Pharmaceutical Ingredients
Favorite
T1230-11-72 - Evaluation of an Acid-Treatment Procedure on the Interference of Anti-Drug Antibodies in a Pharmacokinetic Assay
Favorite
T1330-11-74 - Extracellular Vesicles Derived from Brain Endothelial Cells for DNA Delivery
Favorite
W0930-12-77 - Fit-for-Purpose Immunoassay Development for PEG Using DoE and Multiple Platforms
Favorite
M1130-12-79 - Fit-for-Purpose Method Validation of Clinical Biomarker Assays to Show Proof of Biology with Automated Western Blot Technologies
Favorite
M1030-11-73 - Gene Therapy: Strategies to Generate Critical Reagents to Support Assay Development
Favorite
T1430-12-77 - Generation of High-Resolution Metabolite Profiles by HPLC+AMS
Favorite
T0930-12-77 - Generic Method for Quantitation of Human Fc-Fusion Proteins in Mouse Plasma Using BLI Technology
Favorite
T1530-11-73 - High-Performance Liquid Chromatography Method Development and Validation for the Determination of Celastrol in Rat Plasma
Favorite
M1430-11-71 - High-Throughput In Vitro Assays for Immunogenicity Predictions and Risk Assessment
Favorite
M1330-11-75 - Identification of Asparagine Enantiomers and Their Hydrates by Terahertz Time-Domain Spectroscopy
Favorite
T1230-12-77 - Identifications of MabSelect SuRe LX Sepharose Resin and 15 Other Resin Analytes
Favorite
M1130-11-74 - Immune Checkpoint Inhibitor Antibody Drug Conjugate for Chemotherapy Guided Immunotherapy of Solid Tumors
Favorite
M1130-11-71 - Improving the Encapsulation of Gedatolisib, a Weakly Hydrophobic Drug with Limited Aqueous and Non-aqueous Solubility, in Polymeric Nanoparticles via Flash Nanoprecipitation
Favorite
M1030-11-71 - In Vitro Assessment of Immunogenicity for an Exploratory Gonorrhea Vaccine
Favorite
T1430-11-71 - Influence of Penetration Enhancers on Drug Deposition in Different Skin Layers Using Exercised Human Cadaver Skin
Favorite
T1330-12-78 - Laser Microdissection-LC-MS/MS Method for Quantitative Tissue Distribution Analysis (QTDA) of Tumor Tissue
Favorite
T0930-12-78 - LC-MS Method Development for Quantitation of Midazolam, Ketamine and Their Metabolites: Application to a Pharmacokinetic Study in Patients on Extracorporeal Membrane Oxygenation Therapy
Favorite
T1030-11-73 - LC-MS/MS Method for Quantification of Orexin-A in Plasma, a Biomarker for Narcolepsy
Favorite
T0930-11-71 - LC-MS/MS Quantification of Polypeptide ACTH in Human Plasma for Pharmacokinetic (PK) and Toxicokinetic (TK) Studies
Favorite
M1230-11-74 - Lipid Nanoformulations of Vancomycin and Cefazolin in Methicillin-Resistant
Staphylococcus aureus
Superbug Infection: A Perspective on Efficacy and Uptake
Favorite
W1130-11-73 - Lipid Nanoparticle for Active Targeted Delivery of Vancomycin in MRSA Infection
Favorite
T1530-11-72 - Lower Exposure of Simvastatin and Its Active Metabolite in NAFLD Rat Caused by Lower Intestinal Absorption and Higher Biliary Excretion
Favorite
W0930-12-79 - Magnetic Biosensors for Characterizing Protein-Protein Interactions in Complex Biological Matrix
Favorite
M0930-12-77 - Modernization of Insulin Bioidentity Testing with In-Cell Western Technology
Favorite
T1230-12-78 - MSD and Ella Multiplex Assay Development of IFN-γ, CCL8 and CXCL10
Favorite
T1230-11-71 - MSD GOLD™ Streptavidin and Small Spot Streptavidin Plates: Multi-year Reproducibility and Application to Pharmacokinetic Assay Development
Favorite
M1430-12-79 - Neurofilament Light (NfL) is a Bona-fide Blood Based Biomarker for Neurodegenerative Diseases
Favorite
W1230-12-78 - New Bio-compatible Physiological Bicarbonate Buffer System for Dissolution Testing
Favorite
W1230-11-73 - Novel Elvitegravir Nanoformulation for Drug Delivery Across the Blood-Brain Barrier to Achieve HIV-1 Suppression in the CNS
Favorite
T1330-11-71 - Optimization of a Commercial ELISA to Measure Serum -Defensin 2 in Patients with Psoriasis
Favorite
M1130-11-72 - Optimization of Solid Lipid Nanoparticles to Deliver Efavirenz to Brain for Treatment of Neuro-AIDS
Favorite
T1430-12-79 - Overcoming Stability Issues in the Development of an LC-MS/MS Method for the Quantitation of Azacitidine in Human Plasma
Favorite
W1030-12-80 - PandA Optimization Strategy: Keys to Producing Meaningful Immunogenicity Data and Avoiding the Pitfalls of this Highly Drug Tolerant Format
Favorite
M1130-11-73 - PD-1 siRNA-Solid Lipid Nanoparticles Inhibit Tumor Growth
Favorite
T1230-11-74 - PEGylation Affects the Pharmacokinetic Assessment of Pegfilgrastim Using Ligand Binding Assays
Favorite
M1430-12-78 - Pharmacokinetic and Pharmacodynamic Herb-Drug Interactions between Simvastatin and Gardenia Jasminoids in Healthy and NAFLD Rats
Favorite
M1530-11-71 - Pharmacokinetics of Novel Organic Carbon Monoxide Prodrugs BW-CO-115 and BW-CO-203 via Oral Administration
Favorite
T1230-12-82 - Photoacoustic Nano-Diagnostics of Solid Tumors
Favorite
T0930-11-73 - PK Assay Variability Linked to Plate Positional Effects on MSD Plate Reader
Favorite
M1130-12-78 - Platform Comparisons for Measurement of CCL18: ELISA, IMPACT, and ELLA
Favorite
T1130-11-72 - Pre-existing Antibodies to Biotherapeutics: Two Case Studies for Immunogenicity Assay Design and Appropriate Cut Point Determinations
Favorite
M1030-12-78 - Profiling the Promoter Activity of Different L1 Families in the Mouse Genome to Build an Endogenous Animal Model for Drug Screening
Favorite
W1030-12-79 - Qualification of a Drug-Tolerant Anti-Drug Antibody Assay for C1 Inhibitor in Human Serum
Favorite
M1130-11-75 - Quantification of Chimeric Antigen Receptor T Cells in Blood with a Novel Quantitative PCR Methodology-Recommendation of the Use of the Volume-Based Unit (copies/μL) for the Cellular Kinetic Studies
Favorite
T1530-12-78 - Quantification of Dehydroepiandrosterone (DHEA), 17α-hydroxyprogesterone (17-OHP) and 17α-hydroxypregnenolone (17-OHPreg) in Human Serum Using AB Sciex Triple Quad 5500 LC MS/MS System
Favorite
T1030-12-77 - Quantitation of Biotherapeutics via LCMS - Surrogate Peptide versus Intact Mass Analysis
Favorite
T1030-12-82 - Quantitation of IgG in Human Serum with LC-MS/MS Bottom-Up Strategy
Favorite
M1130-12-77 - Quantitation of Myostatin/GDF8 in Human Serum Using an Enzyme Linked Immunosorbent Assay (ELISA)
Favorite
M1530-12-77 - Quantitation of siRNA and Its Metabolites in RNA-Induced Silencing Complex in Rat Liver Using Immunoprecipitation LC-MS/MS (IP-LC-MS/MS)
Favorite
T1130-11-71 - Rapid In-House Determination of Cut Point Values for Immunogenicity Assays Using JMP and Excel
Favorite
W1030-12-81 - Re-validation of an Immunogenicity Method Following the Issuance of the Finalized FDA Guidance and Assessing the Impact on Clinical Data Interpretations
Favorite
T1230-12-79 - Robust Chemometric Analyses of 2D-NMR Methyl Fingerprints for mAb Therapeutics
Favorite
M1430-11-72 - Screening for Pre-existing Neutralizing Antibodies against AAV Serotypes 1, 2, 5, 6, 8 and 9 In Sera of Different Strains of Pigs
Favorite
W1030-11-74 - Serological Prevalence of Toxoplasmosis in Pregnant Women in Luanda (Angola): Diagnosis of
Toxoplasma gondii
on Placental Fragments by Nested-PCR
Favorite
M0930-11-72 - Simultaneous Detection and Quantification of Lapatinib and Capecitabine in Plasma and Tissue Using a Sensitive Liquid Chromatography-Tandem Mass Spectrometry Method
Favorite
M1530-12-80 - Simultaneous Determination of Coproporphyrin-I and Coproporphyrin-III in Human Plasms and Human Urine Using LC-MS/MS
Favorite
M1530-11-74 - Simultaneous Quantitative Analysis of Anti-infectious Disease Drug Classes in Human Plasma by LC-MS/MS
Favorite
T1130-12-77 - Spectral Investigation into Qualitative Evaluation of Interaction between Doxorubicin Hydrochloride Entrapped within Poly(butyl)cyanoacrylate Nanoparticles
Favorite
W0930-11-72 - Stability Testing of Compounded Enoxaparin Sodium Injection in Pre-filled Syringesby Using HPLC Isocratic Method
Favorite
W1030-12-82 - Standardized and Efficient Modular Automation of a DOE Driven Method Development of a Solution Phase Bridging ELISA Assay to Support Immunogenicity Assessment
Favorite
W1030-12-77 - Strategies for Overcoming Drug Target Interference in Anti-Pembrolizumab Antibody Detection
Favorite
M0930-12-79 - Streamlined Impurity Analysis Using High Throughput Analytical Automation to Support Process Development and Characterisation Studies
Favorite
W1030-11-73 - Systematic Assay Screening for Specific Biomarker Analysis: Circumvent Antibody Bias
Favorite
T1430-11-72 - The Application of Light-Absorbing Photostabilizers for the Determination of Protoporphyrin IX in Human Plasma by LC-MS/MS
Favorite
M1230-11-73 - The Induction of Effective Cancer Immune Response by the Combination of Lipid Based Bubbles and Therapeutic Ultrasound
Favorite
T1030-12-78 - The Relationship between Selectivity and Drug Delivery Efficiency of Peptide-Drug Conjugate: A Comparison of Three EGFR-Targeting Peptide-Drug Conjugates with Different Affinities
Favorite
M1430-12-77 - Tracing Drug Induced Liver Injury (DILI) signatures by Harnessing Cancer Cell Lines
Favorite
T0930-12-79 - Turning a Negative to a Positive with Anti-metatype Affimer Reagents
Favorite
M1530-12-79 - Ultrasensitive Bioassay for Detection of a TNFα-Specific Antibody in Mouse Samples from Rectal vs IV Administration
Favorite
T1530-12-79 - Ultra-sensitive Immunoassay Characterization using Endogenous Validation Samples.Ultra-sensitive Immunoassay Characterization using Endogenous Validation Samples
Favorite
M1030-11-72 - Using Monosaccharide Peptide/Protein Conjugates as Surrogates to Better Understand Protein-Polysaccharide Conjugate Vaccine Structures
Favorite
M1430-11-75 - Validation of a cell lysate based assay to detect antibodies against CFTR
Favorite
T1030-12-81 - Validation of Multiple LC-MS/MS Methods for Quantification of Bevacizumab and Ranibizumab in Human Plasma after Intravitreal Administration
Favorite
M1230-12-77 - Validation of Quantitative Ligand Binding Assay Using Mouse Serial Sampling
Favorite
Clinical Pharmacology
W1130-13-87 - A Clinical Study Design to Evaluate Whether the Systemic Bioavailability of Topical Drugs may Influence the Assessment of Local Dermal Pharmacokinetics by Dermal Open Flow Microperfusion (dOFM)
Favorite
T1430-13-83 - A Drug-Drug Interaction Study to Study the Effects of Multiple Doses of the CYP3A4 Modulators Itraconazole and Rifampin on the Single Dose Pharmacokinetics of Vatiquinone
Favorite
T0930-13-88 - A Drug-Drug Interaction Study: The Effect of Multiple Doses of Vatiquinone on the Single Dose Pharmacokinetics of Tolbutamide and Omeprazole
Favorite
W1030-13-83 - A Modeling Approach to Predict the Outcome of a Bioequivalence Study: Application to a Triple Combination Tablet of Amlodipine/Irbesartan/Hydrochlorothiazide
Favorite
T1330-13-85 - A Multiscale Mathematical Model to Study Nanomedicine Delivery in Solid Tumors
Favorite
M1530-13-85 - A Pharmacokinetic Study of Two Oxybutynin Transdermal Formulations with Transient Heat Exposure
Favorite
M1130-13-89 - A Population PK-PD Model to Characterize the Increase in Gastrointestinal Motility by YH12852, a Highly Selective 5-HT4 Receptor Agonist, in Healthy Subjects and Patients with Functional Constipation
Favorite
M1030-13-85 - A Retrospective Investigation of Bioanalytical Issues in Pharmacodynamic (PD) Studies Submitted in Abbreviated New Drug Applications (ANDAs) for Low Molecular Weight Heparin (LMWH) Drug Products
Favorite
T1330-13-88 - A Target-Mediated Drug Disposition Population Pharmacokinetic Model of GC1118, a Novel Anti-epidermal Growth Factor Receptor Antibody, in Patients with Refractory Solid Tumors
Favorite
T1130-13-86 - Anti-inflammatory Effect oF Selective CB2 Inverse Agonists in Murine and Human Microglial Cells
Favorite
T1130-13-83 - Application of Delay Differential Equations in Modeling Absorption Problems Related to Irbesartan Pharmacokinetics
Favorite
M1030-13-84 - Application of Physiologically-Based Pharmacokinetic Absorption Modeling and Simulations: Risk Assessment and Control of Critical Quality Attributes for Medical Countermeasure Drug Products
Favorite
T1030-13-87 - Applications and Benefits of Healthy Volunteer Trials to Accelerate Oncology Drug Development
Favorite
T1130-13-87 - Assessing OATP1B1- and OATP1B3-Mediated Drug-Drug Interaction Potential of Vemurafenib In Vitro in the Presence of Protein Binding and Using Static and Physiologically-Based Pharmacokinetic Models
Favorite
M1330-13-84 - Assessment of Target Inhibition Using a Pharmacokinetic/Pharmacodynamic Model following Intravitreal Administration of an Anti-HtrA1 Antigen-Binding Fragment in a Phase I Study
Favorite
W0930-13-84 - Assessment of the Impact of Drug Dissolution on Pharmacokinetics of Diltiazem Extended Release Drug Products Using Physiologically Based Pharmacokinetic Analysis
Favorite
W0930-13-88 - Biopharmaceutic In Vitro In Vivo Extrapolation (IVIV_E) Informed PBPK Model of Ritonavir Norvir
®
Tablet Absorption in Humans Under Fasted and Fed State Conditions
Favorite
M1430-13-86 - Biopharmaceutical Profile, Bioavailability, Food Effect, and Pharmacokinetics of Vericiguat: A Novel Soluble Guanylate Cyclase Stimulator
Favorite
M1530-13-86 - Brain Metabolism of cis- and trans-Permethrin
Favorite
T0930-13-86 - Buffer Capacity of Topical Products: In Vitro and In Vivo Proof and Clinical Significance
Favorite
T0930-13-83 - Circulating Endothelial Cells (CECs) as a Diagnostic and Prognostic Marker for Pulmonary Arterial Hypertension (PAH): A Proof of Concept Study in PAH Patients
Favorite
M1130-13-87 - Comparing the Performance of First-Order Conditional Estimation (FOCE) and Different Expectation-Maximization (EM) Methods in Handling Complex Nonlinear Parent-Metabolite Pharmacokinetic Model
Favorite
W1230-13-84 - Comparison of Three Topical Drug Permeation Enhancers in Human Cadaver Skin Using Conventional Franz Cell Permeation and Mass Spectrometry Imaging
Favorite
T1530-13-87 - Compartmental Pharmacokinetic Model Analysis of Vincristine and Its M1 Metabolite in Kenyan Pediatric Cancer Patients
Favorite
T1530-13-89 - Consistent Lung Delivery of Inhaled Triple ICS/LAMA/LABA Fixed-Dose Combination Using Co-suspension Delivery Technology: An In Silico Modeling Study
Favorite
W1130-13-84 - Dermatopharmacokinetic Assessment of Bio(in)equivalence of Topical Metronidazole Creams Using Tape Stripping
Favorite
T1230-13-87 - Design, Synthesis and Biological Screening of Novel Quinazoline and Pyrrolotriazine Derivatives as Potent HER-2 and VEGFR2 Inhibitors
Favorite
M1030-13-88 - Developing a Physiologically Based Pharmacokinetic Module of Sofosbuvir to Predict a Pediatric Population Dose Using Simcyp Simulator
Favorite
T1330-13-84 - Development and Verification of a Physiologically Based Pharmacokinetic – Pharmacodynamic (PBPK-PD) Canine Model for Propofol in Greyhounds and Beagles
Favorite
T1330-13-87 - Development of a PBPK Model for the Prediction of Amiodarone Pharmacokinetics in Fed and Fasted State Using the Advanced Dissolution, Absorption and Metabolism (ADAM) Model
Favorite
M1030-13-89 - Development of a Physiologically Based Pharmacokinetic (PBPK) Model for Intra-articular Delivery
Favorite
W0930-13-87 - Development of Pharmacokinetic Evaluation System for Effective Formulation Design (X): The Study of the Gastrointestinal Behavior under Dosing OD Tablets without Water by Using GastroPlus
TM
Favorite
M1530-13-87 - Development of Pharmacokinetic Evaluation System for Effective Formulation Design for Generic Medicines: Prediction of Drug Absorption from OD Tablets Containing Poorly Water-Soluble Drugs in Human
Favorite
M0930-13-84 - Differential Genome-Wide H3K9 Acetylation Changes Induced by DNA Hypomethylating Agents
Favorite
T1230-13-86 - Differential Packaging of Cytokines/Chemokines in Macrophages-Derived Exosomes upon Exposures to Tobacco and HIV: Potential Role of These Exosomes in Smoking-Induced HIV Pathogenesis
Favorite
M1430-13-87 - Efavirenz Physiologically Based Pharmacokinetic Model Development and Validation as a Moderate CYP3A4 Inducer for Drug-Drug Interaction Predictions
Favorite
M1530-13-83 - Effect of Food on the Pharmacokinetics of Monomethyl Fumarate After Administration of Diroximel Fumarate
Favorite
M1230-13-84 - Efficacy of Millets as Adjuvant to Chemotherapy in Reducing Adverse Effects in a 56 Year Old Female Patient Reported with Stage 4 Advanced Ovarian Cancer
Favorite
T1530-13-86 - Establishment of a Hollow Fiber Infection Model for Preclinical PK/PD Evaluation of Novel Spectinamide Antituberculosis Agents
Favorite
M0930-13-88 - Estimation of Brain Entry Rate of Oxycodegol, a Selective, Long-Acting Full µ-opioid Receptor Agonist, in Humans Using PBPK-PD Modeling
Favorite
M1230-13-86 - Evaluating Food Effects on Oral Drug Absorption in Infants: An Exploratory Study in Healthy Adults
Favorite
T0930-13-85 - Evaluation of Different Inhibitory Effect of Itraconazole and Clarithromycin on Hepatic CYP3A Activity Using Oral Sildenafil and Endogenous Metabolic Markers for Hepatic CYP3A Activity
Favorite
T1430-13-85 - Evaluation of Dried Blood Spot Sampling Method toward Therapeutic Monitoring of Radotinib in the Treatment of Chronic Myeloid Leukemia
Favorite
M1430-13-88 - Evaluation of Methamphetamine and Amphetamine Disposition Discrepancy upon Selegiline Transdermal Patch Administration in Healthy Volunteers Versus Special Populations Using PBPK Modelling
Favorite
T1030-13-85 - Evaluation of U.S. FDA Approved Generic Oral Solution Products
Favorite
W0930-13-89 - Exploring Clinical Relevance of Dissolution Testing by Physiologically Based Biopharmaceutics Modeling (PBBM)
Favorite
M1130-13-85 - Exposure Predictions of Prodrug CZ48 and Active Campothecin, CPT, in Humans: Population PK Modeling and Simulation of CZ48 and CPT
Favorite
T1030-13-89 - FDA Perspective on Current Challenges in Bioequivalence Evaluation for Topical Dermatologic Corticosteroid Abbreviated New Drug Applications (ANDAs)
Favorite
T1030-13-88 - FDALabel: Database on the Amazon Cloud for Drug Labeling Information
Favorite
M1030-13-87 - Gender Differences in Pharmacokinetics, Excretion Pattern, and Tissue Distribution Following Administration of 4-n-nonylphenol in Rats
Favorite
T0930-13-84 - Impact of Operator Variability on the Reproducibility of Tape Stripping Results
Favorite
T1230-13-85 - In Vitro and In Vivo Interpretations of Effect of Isoflurane Anesthesia on Membrane Lipids of Blood-Brain Barrier: Potential Clinical Implications
Favorite
M0930-13-86 - In Vitro Study of Novel Bone-Targeting Angiotensin 1-7 Conjugate Effects on Cell Survival and mRNA Expression of Different Components of Renin-Angiotensin System in Various Cancer Cell Lines
Favorite
W1030-13-87 - Inflammation Responsive Drug Delivery for Localized Opioid Release to Combat Chronic Pain in Osteoarthritis
Favorite
T1230-13-83 - Influence of Rifampin-Mediated OATP1B1/1B3 Inhibition on the Pharmacokinetics of Clazosentan
Favorite
T1330-13-86 - Investigating the Impact of Crohn's Disease on Oral Budesonide Pharmacokinetics Using In Vitro Dissolution Testing and PBPK Modeling
Favorite
T1430-13-84 - Investigations of Catheter Obstructions from Materials Collected in Patients with Type 1 Diabetes Treated by Intraperitoneal Insulin Infusion
Favorite
T1430-13-87 - IPE between PharmD and Exercise Science Students
Favorite
M0930-13-85 - Lipidomic Alterations in Docetaxel-Resistant Prostate Cancer
Favorite
T1530-13-84 - Longitudinal Impacts of Roux-en-Y Gastric Bypass Surgery on the Atorvastatin and Simvastatin Metabolisms and 3D PK/PD Correlations
Favorite
T1530-13-83 - Mass Balance, Metabolic Disposition, and Pharmacokinetics of [
14
C]Etrasimod Following Oral Administration to Healthy Male Volunteers
Favorite
M1330-13-86 - Mean Residence Time Values for Monoclonal Antibody Drugs
Favorite
T1530-13-85 - Mechanism-Based Population Pharmacokinetic/Pharmacodynamic (PKPD) Modeling of ISIS 702843, a TMPRSS6 Targeting Antisense Oligonucleotide (ASO) to Guide Early Clinical Development
Favorite
T1130-13-84 - MEK1/2-Mediated Chemosensitization in Glioblastoma Cells
Favorite
M1430-13-85 - Microdosing Strategy for Absolute Bioavailability Studies: A Case Study on
13
C-Venetoclax, from Development to the Clinic
Favorite
W0930-13-83 - Multi-scale PK Modeling of Biotherapeutic Formulations Injected in Human Subcutaneous (SC) Tissue
Favorite
W1030-13-86 - Nasal Immunization Induces Nicotine-Neutralizing Antibodies in Blood and Lung Mucosal Secretions
Favorite
T1230-13-84 - New Oral Diabetic Macular Edema/Diabetic Retinopathy Treatment Using First-in-Class Mode of Action
Favorite
T1330-13-83 - Nonlinear Mixed Effect Modeling of Donepezil After Oral Administration
Favorite
M1230-13-89 - PBPK and Its Virtual Populations: Simulation of Pharmacokinetic Parameters in Pediatric Population Using Developed Furosemide Simcyp Model
Favorite
T0930-13-87 - Pharmacokinetic Drug-Drug Interaction between Teneligliptin and Atorvastatin in Healthy Male Adults
Favorite
M1330-13-85 - Pharmacokinetic Interaction between Fixed-Dose Combination of Ezetimibe/Rosuvastatin and Fixed-Dose Combination of Telmisartan/Amlodipine in Healthy Male Subjects
Favorite
M1030-13-83 - Pharmacokinetic Similarity of Test and Reference Anti-epileptic Drugs in Generic Brittle Patients with Epilepsy
Favorite
W1130-13-83 - Pharmacokinetic Study of Physically Manipulated Oxycodone Hydrochloride Products Following Nasal Insufflation in Recreational Opioid Users
Favorite
T1030-13-84 - Pharmacokinetics of Diroximel Fumarate in Healthy Volunteers, Adults with Renal Impairment and Patients with MS
Favorite
W0930-13-85 - Physiologically Based Pharmacokinetic Model for Voriconazole and Prediction of Its Interactions with Midazolam and Alfentanil
Favorite
M1430-13-83 - Population Modeling for the Investigation of Factors Affecting the Clinical Outcome in Epileptic Patients Under Levetiracetam Therapy
Favorite
M1130-13-86 - Population Pharmacokinetics of Cefazolin Before, During, and After Cardiopulmonary Bypass in Japanese Patients Undergoing Cardiothoracic Surgery
Favorite
W1230-13-86 - Potent Inhibitory Effect of Vandetanib on Methotrexate-Induced Epithelial-Mesenchymal Transition in Alveolar Epithelial A549 Cells
Favorite
M1230-13-88 - Predicting Shrinkage of Individual Parameters in More Complex NLME Models Using Bayesian Fisher Information Matrix
Favorite
W0930-13-86 - Prediction of Pulmonary Pharmacokinetics of Spectinamide 1599 in Humans Based on Rodent Pharmacokinetic Data Using a Permeability-Limited Lung Physiologically Based Pharmacokinetic Model
Favorite
W1130-13-86 - Randomized, Open-Label, Single-Dose, Crossover Pharmacokinetic Study of Multiple-Dose and Single-Dose Vial Epoetin Alfa-Epbx, an Epoetin Alfa Biosimilar, by Subcutaneous Dosing in Healthy Subjects
Favorite
W1230-13-85 - Relationship Between TGF-β1-Induced EMT and Monocarboxylate Transporter 1 (MCT1) in Alveolar Epithelial A549 Cells
Favorite
M1230-13-83 - Relationship of AEDs to Generic Brittleness and to Switch Problems in Patients with Epilepsy
Favorite
M1130-13-88 - Role of IL-23 suppression in psoriasis – insights from meta-analysis of clinical data
Favorite
T1030-13-83 - Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACT017, an Anti-platelet GPVI (Glycoprotein VI) Fab in Healthy Volunteers
Favorite
M0930-13-87 - Steady-State Trough Concentrations and Their Relationship to Selected Demographic and Clinical Response Measures in Etrasimod-Treated Patients with Moderately-to-Severely Active Ulcerative Colitis
Favorite
M1030-13-86 - The Effect of the Local Tissue Response on the Pharmacokinetics of Long-Acting Injectable Formulations
Favorite
T1430-13-86 - The Expression of SLC7A11 Transporter in Ovarian and Colon Cancer Tissues at Different Stages of Development
Favorite
M1130-13-83 - The Impact of Dose and Time Delay Between Administration and Absorption on Irbesartan Pharmacokinetics and Pharmacodynamics
Favorite
T1530-13-88 - The Impact of Glycosylation Composition on Pharmacokinetics (PK) of Monoclonal Antibodies
Favorite
W1130-13-85 - The Pharmacokinetic Differences between Humans and Animals of KZR-616, a First-in-Class, Selective Immunoproteasome Inhibitor, in Two Clinical Formulations
Favorite
W1230-13-87 - The Use of Concatemer Subunit Constructs to Study the Pharmacology of α4- and α6-Containing Neuronal Nicotinic Acetylcholine Receptor
Favorite
M1230-13-85 - The Viscosity of Contents in the Upper Gastrointestinal Lumen of Adults in the Fed State
Favorite
M1130-13-84 - Translating Progressive Disease Pharmacokinetic Model to Clinical Application: An Interactive Dosing Guidance Support Tool for Riluzole Therapy in Spinal Cord Injury Patients
Favorite
T1030-13-86 - Trends in the Design and Conduct of Pharmacokinetic Studies in Patients with Impaired Hepatic Function
Favorite
M1430-13-84 - Using a Physiologically-Based Pharmacokinetic Absorption Model to Establish Clinically Relevant Dissolution Safe Space for Oseltamivir in Adult and Pediatrics
Favorite
M1230-13-87 - Using Resampling to Improve Model Selection in Pharmacometrics
Favorite
M1530-13-84 - Visualizing and Evaluating the Impact of Immunogenicity on Pharmacokinetics
Favorite
W1030-13-85 - Zt/g4-MMAE, a RON Receptor-Targeted Antibody-Drug Conjugate with Potent Anti-tumor Activity Against RON-Overexpressing Solid Tumor Models
Favorite
Formulation and Quality
M1030-02-08 - A Cancer-Targeting Liposomal Delivery System for Photodynamic Diagnosis and Therapy of Cancers in Peritoneal Cavity
Favorite
M1430-06-41 - A Clinically Relevant Non-sink Dissolution Method for ASD-Based Formulations
Favorite
M1430-01-04 - A Comparative Study of Lipid-Based Nano Drug Delivery System Using MSP1D1 Protein and Poloxamer 407
Favorite
T1330-04-27 - A Comparative Study of Various Approaches to Generate Soluble Dosage Forms
Favorite
W0930-07-45 - A Comparison Among the In Vitro Release Profiles and the In Vitro Absorption Profiles of Caffeine from Three Lipophilic Topical Formulations
Favorite
T1230-04-24 - A Comparison of KinetiSol®-Processed and Spray Dried Amorphous Solid Dispersion Release Kinetics via pH-Dilution Dissolution
Favorite
T1230-05-32 - A Comparison of the Economical and Experimental Outcomes of Different Ratios and Types of Fillers in Direct compression Process of Solid-Dosage Form in order to Evaluate the CQA of Glucosamine Tablets
Favorite
W1030-02-09 - A Comparison of the Permeability of Lidocaine Formulations Through a Shed Snake Skin Model of Stratum Corneum Using Franz Diffusion Chambers and an Air Interface Chamber
Favorite
M0930-01-01 - A Comparison of the Spray Characteristics of Aqueous and Non-aqueous Multi-dose Nasal Spray Formulations
Favorite
M1330-01-05 - A Corneal-Penetrating Eye Drop Formulation for Enhanced Therapeutic Efficacy of Soft Corticosteroids against Anterior Uveitis
Favorite
T0930-02-08 - A Fast HPLC Method for Drug Dimerization Rate and Drug Release Tests
Favorite
M1530-05-34 - A Film Coating Formulation That Has a Better Performance for Tablet Printing
Favorite
W1230-03-15 - A Functional Wound Dressing Intended for Cutaneous Leishmaniasis
Favorite
M1330-04-23 - A Fundamental Study on Strain Rate Sensitivity of Spray Dried Solid Dispersions
Favorite
T1330-01-07 - A Long-Acting Thermo-Responsive Injectable Formulation of Tin Protoporphyrin IX Dichloride: Development and In Vitro In Vivo Evaluation for Tuberculosis Treatment
Favorite
T1330-06-37 - A Modified Langmuir-Like Equation to Account for Solvent Displacement in Drug Adsorption from Aqueous Solutions
Favorite
T1530-02-14 - A New Injectable Liquid Crystal System for One Month Delivery of Leuprolide
Favorite
M1030-05-32 - A New Kollicoat
®
Polymer Coating as a Moisture Barrier for Soft Gelatin Capsules
Favorite
T1430-04-27 - A Novel Amorphous Solid Dispersion Based on Drug-Polymer Complexation
Favorite
T1430-03-21 - A Novel Approach to Improve Bioavailability of Poorly Water-Soluble Drugs
Favorite
M1230-03-17 - A Novel Laser Diffraction Methodology for the Characterization of ASD Speciation Events - An Itraconazole: HPMC AS Case Study
Favorite
T1430-06-38 - A Novel Patient-Specific In Vitro Drug Release Model That Allows Assessing the Variability of In Vivo Drug Release in Patients Suffering from Parkinson´s Disease
Favorite
M1130-07-47 - A Novel Stereolithographic Platform for 3D-Printing a Six-Layered Printlet Containing Different Drugs
Favorite
M1130-02-08 - A Novel Sunflower Oil-Based Polyol Urethane for Olanzapine Delivery
Favorite
T1230-03-18 - A Novel Ufosomal Formulation for Topical Delivery of Clotrimazole
Favorite
W0930-05-33 - A One-Step Continuous Twin Screw Process Using Neusilin® S2 to Improve Solubility of Poorly Soluble Drug Indomethacin
Favorite
W1030-04-23 - A Phase I Study to Screen Multiple Solubility-Enhancement Formulation Technologies and an Assessment of Food, PPI and Dose Linearity with the Selected Formulation of BOS172767 in Healthy Volunteers
Favorite
T1330-07-43 - A Polymeric Bio-adhesive Film Forming Topical Spray Formulation Providing a Bi-phasic Release Profile for the Treatment of Neuropathic Pain
Favorite
M1130-06-40 - A Selective and Sensitive Method Development and Validation of 1,1-Dimethyl-3-Hydroxy-Pyrrolidinium Bromide Impurity in Glycopyrrolate Bromide by Liquid Chromatography – Tandem Mass Spectoscopy
Favorite
M1030-07-47 - A Straightforward Compounding Method for Reproducible Homogenous Carbomer 940 Based Lidocaine Gel
Favorite
T1030-04-26 - A Strategy to Use Raman Spectroscopy to Enable High-Throughput Screening of Oral Lipid Drug Formulations
Favorite
M1130-01-07 - A Study on the Effect of Drug-Polymer Ratio on the Characteristics of Levonorgestrel Microparticles Prepared Using Poly-L-lactic Acid
Favorite
T1530-07-49 - A Supersaturatable Self-emulsifying Drug Delivery System for the Weakly Basic Drug Carvedilol to Improve Its Bioavailability
Favorite
M1430-04-25 - A Surfactant-Based Binary and Triple Solid Dispersion Technique for the Dissolution Enhancement of Mosapride
Favorite
T1130-06-39 - Abbreviated Dynamic Vapor Sorption (DVS) Analysis Method for the Determination of Amorphous Content in Micronized Drug Substance
Favorite
M1030-06-39 - Absorptive Dissolution Testing: An Improved Approach to Study the Impact of Residual Crystallinity on the Performance of Amorphous Formulations
Favorite
T1430-05-29 - Abuse Deterrent Compositions of Poly(ethylene Oxide) and Crosslinked Carboxymethylcellulose
Favorite
M1330-07-47 - Abuse-Deterrent Therapeutic Complexes of Dextromethorphan and Crosslinked Starch and Cellulose Derivatives
Favorite
W1030-01-07 - Accelerate Development of Topical Cream Drug Product Using a Common Platform Base Formulation
Favorite
M1230-06-36 - Accelerated siRNA Analytical Denatured IP-RP UPLC Method Development Using Fusion Software
Favorite
T1530-06-40 - Accelerated Stability Modeling of Drug Products using ASAP
prime
®
Favorite
M0930-04-23 - Acoustic Fusion as a New Method for Generating Small Scale Amorphous Dispersion Formulations
Favorite
M1030-03-17 - Active Natural Oil-Based Nanoemulsion Containing Tacrolimus Loaded Gel for Synergistic Anti-psoriatic Efficacy
Favorite
T1530-07-43 - Additive Manufacturing of Pharmaceutical Tablets with Wider Range of Drug Loadings via FDM 3D Printing
Favorite
M1230-05-33 - Agonist and Antagonist Release Modulated Microenvironment Sensitive Pills for the Prevention of Accidental or Abuse Related Use of Sleeping Pills
Favorite
T1330-02-13 - Albumin Drug Conjugate Delivering Highly Potent Drug with Improved Tumor Accumulation and Anti-tumor Efficacy
Favorite
T1530-05-35 - Alterations in Tablet Properties and Formation of Internal Cavities Account for the Humidity-Induced Deterioration of Orally-Disintegrating Tablet Hardness
Favorite
T1330-04-26 - Ameliorating Brain Delivery of Paliperidone via Lipid Nanoconstructs: Formulation and In Vitro Evaluation
Favorite
W0930-05-35 - Ammonio Methacrylate Co-polymer Nanoparticles Serve as Effective Anticancer Immunotherapeutics
Favorite
M1330-03-18 - Amorphous Nanocomplex of Efavirenz Loaded Vaginal Film (EZfilm) for Preexposure Prophylaxis (PrEP) of HIV
Favorite
T1430-04-24 - Amorphous Solid Dispersion and Self-Microemulsifying Drug Delivery System Comparison of a Novel Compound In Vitro and Bioavailability In Vivo
Favorite
T1430-03-18 - Amphotericin B Loaded Nanostructured Lipid Carriers for Ocular Drug Delivery in Cases of Ocular Fungal Infections: In Vitro and In Vivo Evaluations
Favorite
M1330-05-29 - An Easy-to-Swallow Immediate Release Coating Formulation with Instacoat Aqua Lustre
Favorite
T1030-02-14 - An Innovative Calculation-Based Approach for Biologics Ruggedness Study Sample Preparation
Favorite
T0930-01-03 - Analysis of HPMC and Gelatin Capsules for Optimal Aerodynamic Performance of Salmeterol-Fluticasone Inhalation Formulation
Favorite
W1030-03-16 - Analysis of Tamoxifen Localization in The Polyethyleneglycol-Polylactide Block Copolymer Micelles with Different Physicochemical Properties by Solid Phase Extraction
Favorite
W1230-01-03 - Analytical and Biophysical Characterization of lyophilized Immunoglobulin G Tablet Stability during the Compaction and Storage
Favorite
W1030-06-39 - Analytical Method Development, Validation and Stability Studies of a Novel Anti-cancer Drug IND 2
Favorite
T1330-05-31 - Apigenin Self-Nanoemulsifying Drug Delivery System for Enhancing Oral Bioavailability: In Vitro, In Vivo, and Stability Evaluations
Favorite
M0930-07-44 - ApolipoproteinE2 Gene Delivery Using Functionalized Liposomes Across Blood Brain Barrier for Treatment of Alzheimer’s Disease
Favorite
M1030-03-16 - Application and Evaluation of Strat-M™ Artificial Membrane for Predicting Diffusion in Skin Permeation Experiments
Favorite
T1230-06-40 - Application of Freethink's ASAPprime Software to Analyze and Predict the Impact of Storage and Handling Temperature Excursions for Cold-Chain Handling of Netarsudil Ophthalmic Solution
Favorite
M1330-05-33 - Application of Hypromellose Phthalate (HPMCP) and Smart-Ex in the Development of Multiple Unit Pellet System (MUPS) Orally Disintegrating Tablet (ODT) for Lansoprazole 15mg
Favorite
T0930-06-40 - Application of Near Infrared Spectroscopy and Chemometrics for the Quantification of Acetaminophen in Bulk and in Soft Gelatin Capsules
Favorite
T1430-06-41 - Application of NIR for Improvement in Blending Process
Favorite
T1030-03-19 - Application of Plackett-Burman Design to Study the Effect of In Vitro Test Conditions on the Permeation Rate of Etofenamate and Diclofenac from Selected Topical Products through Strat-M
TM
Membrane
Favorite
M1530-05-35 - Applications for the ProCepT Tri-fluid Nozzle in Spray Drying
Favorite
T1230-07-47 - Applying Physiologically Based Pharmacokinetic Modeling and Simulation for Quality Risk Assessment: Setting Clinically Relevant In Vitro Dissolution “Safe Space” Specifications for a BCS Class II Drug
Favorite
W1130-03-19 - Approaches to Develop Acyclovir Gastro-Retentive Formulations Using Hot Melt Extrusion Technology
Favorite
M1330-06-36 - AS04 Enhances Mucosal AndSystemic Immunity To Antigens Following Intranasal Administration
Favorite
M1530-01-01 - Assay of Potassium Bitartrate Using Ion Chromatography
Favorite
T1030-07-45 - Assessing the Effects of Different Lipids on Bioavailability of Cannabidiol following Oral Administration
Favorite
W1130-03-21 - Assessment of Biosimilarity Using Forced Degradation: Rituximab, Bevacizumab, and Trastuzumab Originators and Biosimilars
Favorite
M1530-07-46 - Assessment of Patient Exposure to Leachables from Lyophilized Drug Formulations Following Reconstitution, Storage, and Administration via Polymeric Packaging/Delivery Systems
Favorite
W1030-02-10 - Assessment of Quality Control Parameters and In Vitro Bioequivalence/Interchangeability of Multi-source Marketed Atorvastatin Calcium Tablets in the State of Qatar
Favorite
T0930-04-22 - Assessment of the Impact of an Unusual Reaction between API and HPMCAS Polymer on Long Term SDD Storage
Favorite
T1130-06-38 - BCA Protein Content Determination on Microplate Support: Suitability Study for Alzheimer Vaccine Treatment
Favorite
T0930-02-14 - BE Discriminant In Vitro Dissolution Test for Two Ibuprofen Formulations: Relevance of Buffer Strength and Fluid Volume
Favorite
W1130-04-28 - Bedaquiline-Cyclodextrin Molecular Inclusion Complex for Effective Treatment of Multidrug Resistant Tuberculosis
Favorite
T1030-05-35 - Beta-cyclodextrin Derivatives as a Viable Tool for a BCS Class II Drug (Griseofulvin) Solubilizations
Favorite
M1430-02-12 - Binary Liposomal Platform for the Low-Intensity Light-Induced Release of Doxorubicin
Favorite
M1430-01-02 - Bioadhesive Nanoemulsions Improve Cellular Uptake and Cytotoxicity of Piplartine In Mammary 3d Tumor (Spheroids)
Favorite
M1230-03-16 - Biocompatible Tadalafil Nanoemulsion for Management of Pediatric Pulmonary Hypertension
Favorite
W1030-04-27 - BioDuro Solution Engine: Rapid Development of Regorafenib Spray Dry Dispersions with Minimal Material Use
Favorite
T1330-05-35 - Biorelevant In Vitro Testing of Electrospun Polymeric Nanofibers of Weak Bases with Solubility Limited Oral Absorption: Albendazole as a Case Example
Favorite
M1330-02-09 - Brain Targeting Nanoparticles of Neuropeptide Y: Fabrication and Characterization
Favorite
T1430-06-36 - Captisol
®
improves the Aqueous Solubility of a Poorly Water Soluble Drug Elvitegravir
Favorite
W0930-05-30 - Carbopol
®
Polymers and Noveon
®
Polycarbophil Mucoadhesive Properties in Liquid and Semisolid Formulations
Favorite
M1030-05-31 - Case Study: Formation and Elimination of Stringers on Eudragit Tablet Coatings
Favorite
M0930-07-43 - Cell Assembly-Mediated Delivery of Checkpoint Inhibitors for Leukemia Immunotherapy
Favorite
M1230-06-39 - Challenging Assay Development for Two Different Lidocaine Topical Systems by Using UPLC-PDA in Support of Clinical Studies 2 - Clinical Results and Application
Favorite
M1330-02-13 - Characterization and Pharmacokinetics of a Novel Nano-Lipid Delivery System of Cannabidiol
Favorite
T1130-06-37 - Characterization and Quality Comparison of AmBisome® and Several Generic Products
Favorite
M1230-06-38 - Characterization and Validation of an In Vitro Microglia Cell Line Model to Screen Potential Therapeutics for Neuropathic Pain
Favorite
T1230-05-33 - Characterization of Directly Compressible Starch for Use in a Continuous Manufacturing Line
Favorite
M1530-05-31 - Characterization of Physical Properties of Novel Calcium-Phosphate-Based Starter Pellets (PharSQ
®
Spheres CM)
Favorite
T1130-06-36 - Characterization of Protein Therapeutics: Detection of Small Peptide Aggregates with FFF/MALS Technology
Favorite
M1030-05-35 - Characterization of Spray-Dried Aggregates for Tablet Formulation with Microstructure 3D Imaging Analytics
Favorite
W1130-02-13 - Characterization of the Partition Rate of 2-Naphthol and Ritonavir across the Water - Octanol Interface and the Influence of Common Pharmaceutical Excipients
Favorite
W0930-07-49 - Characterization of the Performance of a Novel Esophageal Drug Delivery System in Humans
Favorite
M1030-02-12 - Characterization Optimization Temozolomide Loaded Magnetic Nanoparticles–In Vitro Evaluation to Study P-gp/EGFR Inhibition Mediated Therapy for Glioblastoma Multiforme
Favorite
W1130-05-35 - Characterizing Deformation Properties of Directly Compressible Excipients Using a Compaction Emulator
Favorite
W1030-06-42 - Characterizing the Effect of Flow Aid Additives on Pharmaceutical Powders
Favorite
M1030-02-14 - Chelerythrine Chloride Nanoparticles in Triple Negative Breast Cancer Chemotherapy
Favorite
T1330-01-05 - Cholecalciferol Solubilization by Hydroxypropyl-β-Cyclodextrin (HPBCD)
Favorite
W1030-05-31 - Chrono Modulated Multiple Unit Particle Systems (MUPS) for Treatment of Angina via Hot Melt Extrusion Technology
Favorite
W0930-04-25 - Co-amorphous Spray Dried Dispersion vs. Physical Mixture of Resveratrol and
Favorite
M0930-04-22 - Cocrystal Solubility Advantage Diagrams, Additive Selection, and Drug Supersaturation-Precipitation Behavior
Favorite
M1130-06-38 - Cocrystallization from Stable Hydrate by Heating Method Using Hot-Stage Low-Frequency Raman Spectroscopy
Favorite
T1030-03-21 - Co-delivery of Adenosine and Niacinamide Utilizing Solid Lipid Nanoparticles for Anti-Wrinkle and Whitening of Skin
Favorite
T0930-02-10 - Co-delivery of MicroRNA 708 and Paclitaxel in Layer-by-Layer Assembled Mesoporous Titania Nanoparticle for Combined Chemotherapy
Favorite
M1230-05-31 - Coenzyme Q10 Orally Disintegrating Tablets
Favorite
M1530-01-03 - Co-formulating a Novel Combination Therapy of Paclitaxel and Calcipotriol for the Treatment of Pancreatic Ductal Adenocarcinoma Using Response Surface Methodology
Favorite
T1030-02-10 - Combination Drug Delivery from an Antibiotic-Releasing Bone Void Filling (ABVF) Putty for Biofilm Related Orthopedic Infection Treatment
Favorite
T1230-02-09 - Combination NIR Therapy and Regulatory T Cell Modulation Using Layer-by-Layer Hybrid Nanoparticles for Effective Cancer Photoimmunotherapy
Favorite
T1530-02-10 - Combination of Personalized Nanovaccines and a Customized In Situ Anti-PD-L1 Depot for Precise Cancer Therapy via a Sequential Immune Enhancement and Immune Normalization Strategy
Favorite
T1430-01-01 - Combinatorial Approach for the Treatment of Neovascular Age-Related Macular Degeneration Using Anti-HIF and Anti-VEGF Agents
Favorite
W1130-02-09 - Combined Chemophototherapy by Lanreotide-Conjugated Hybrid Nanoparticles Wrapped Polyaniline and Methotrexate in Treatment of SSTR-Expressing Cancer
Favorite
M1230-02-12 - Combined Effects of the Supersaturation Rates and Doses on the Kinetic-Solubility Profiles of Amorphous Solid Dispersions Based on Water-Insoluble PHEMA Hydrogels: Proof of Concept in Rats
Favorite
W1030-06-41 - Combining ssHDX and MALDI-HDX as a Novel Semi-automated HTA Workflow to Assess and Predict the Stability of Solid-Dose Peptides Following Mixing and Lyophilization with Various Excipient Formulations
Favorite
T1030-07-43 - Comparative Dissolution and pH Solubility Studies of Indomethacin Solid Dispersions to Explain the Effect of Polymers’ Order of Addition
Favorite
T1130-05-30 - Comparative Dissolution of Different Over-the-Counter (OTC) Acetaminophen Extended-Release Tablets
Favorite
M1330-05-30 - Comparative Evaluation of Commonly Employed Plasticizers in Soft Gelatin Capsules
Favorite
W0930-06-42 - Comparative Evaluation of Pharmaceutical Powders Flow Using Different Analytical Methodologies
Favorite
M1030-01-07 - Comparison of Calcium Glycerol Phosphate Versus Calcium Gluconate Mediated In Situ Gelling of Alginates for Ocular Drug Delivery.
Favorite
T1330-03-21 - Comparison of Human Cadaver Skin with Freshly Frozen Human Surgical Skin for Bioavailability and Bioequivalence Studies
Favorite
M1030-06-41 - Comparison of Solubility and Dissolution Behavior of Ibuprofen and Ketoconazole Immediate Release (IR) Tablets in Biorelevant Medium Made from Commercial Powder or from Scratch
Favorite
T1230-01-07 - Comparison of the Effectiveness of Sildenafil Citrate Air-Jet Nebulizer and Dry Powder Inhaler
Favorite
T1430-04-25 - Comparison of Two In Silico Modeling Programs, ADMET Predictor Ò and Percepta Ò to Predict Intrinsic Solubility and pK
a
of Poorly Soluble Drugs
Favorite
M1330-02-10 - Comparison Study Between SLN and NLC: Release of Rhodamine 123
Favorite
M1330-06-37 - Compatability of Flavoring Agents in Compounding Extemporaneous Omeprazole Oral Liquid
Favorite
T0930-03-15 - Composite Collagen, Alginate and Hyaluronate Based Wound Dressings Loaded with Protein for the Treatment of Chronic Wounds
Favorite
M0930-05-32 - Comprehensive Binder Comparison in Metformin Extrusion Granulation
Favorite
T1430-05-33 - Compression Profiles of a Directly Compressible Starch using Compaction Simulation and High-Speed Tablet Press
Favorite
T1130-03-21 - Conformational Switch-Based pH-Sensitive Liposomes Enhance the Anticancer Activity of Doxorubicin in an Orthotopic Murine Model of Breast Cancer
Favorite
M1530-06-36 - Considerations in the Development and Implementation of Analytical Methods for Understanding and Controlling the Chemical Stability of Formulated Synthetic Peptides
Favorite
M1030-04-24 - Construction of Thermodynamic Phase Diagrams to Predict Drug-Polymer Miscibility in Hot-Melt Extrusion
Favorite
W0930-03-17 - Continuous Production of Raloxifene Hydrochloride Loaded Nanostructured Lipid Carriers Using Hot-Melt Extrusion Technology
Favorite
M0930-06-42 - Contributions to Dissolution Enhancement in Fed-State Biorelevant Media
Favorite
M1430-05-33 - Controlled Release to the Lower Gastrointestinal Tract Using Liquid Filled Hard Capsules
Favorite
M0930-05-35 - Correlation of In Vitro Mucoadhesion and Contact Angles of Hypromellose
Favorite
W1130-01-07 - Correlations between BSA Intrinsic Fluorescence and Aggregation using Multivariate Experimentation
Favorite
T1430-07-43 - C-peptide Determination in Diabetic Rats Treated with Capsules Containing Purified Leaf Extract of
Mangifera indica
and Glibenclamide or Metformin
Favorite
W1030-02-12 - Critical Considerations When Using PAMPA for the Assessment of Membrane Mass Transfer from Supersaturated Solutions of Lipophilic Drug Dompound
Favorite
W1030-07-44 - Critical Quality Attributes of Topical Pharmaceutical Foams
Favorite
M1330-03-20 - Critical Risk Assessment and Prioritizing: A New Tool to Prioritize and Simplify the Toxicological Risk Assessment in the Manufacture of Pharmaceutical Products in Shared Facilities
Favorite
M0930-07-47 - Crosslinked Carboxymethyl Starch and Carboxymethyl Cellulose-Based Formulations: An Innovative Approach to Deter Opioid Drug Abuse
Favorite
T0930-04-24 - Crystal Seed Growth Poisoning by Polymeric Additives in Non-Sink Dissolution of Amorphous Solid Dispersions Containing Residual Crystallinity
Favorite
M1330-05-31 - Crystallographic Evidence of Reduced Dissolution by Surfactant: Salt Formation Between Norfloxacin and Sodium Lauryl Sulfate
Favorite
M1430-03-21 - Curcumin and Cyclosporine Loaded Bioadhesive Pellets for Colon Targeting in the Management of Inflammatory Bowel Disorder: Development, Optimization, In Vitro and Pharmacodynamic Evaluation
Favorite
M1330-07-43 - Cytotherapy for Parkinson's Disease - Smart Microcapsules for Long Term Treatment
Favorite
W1130-03-17 - Dabigatran Etexilate Loaded Nanoemulsion Demonstrating Enhanced Oral Bioavailability and Anticoagulant Activity
Favorite
M0930-06-39 - Dapoxetine Hydrochloride and L-arginine Solid Dispersion Film Formulation for Premature Ejaculation Treatment
Favorite
T1430-03-15 - Decorated HDL Nano-particulates Inspired Tumor Extracellular Dissociation for Site-Specific Chemo-immunotherapy
Favorite
M1230-02-10 - Degradable Hollow Mesoporous Organosilica Nanoparticles for Drug Delivery
Favorite
T1130-06-40 - Degradation Products Profiling of Imatinib Using UHPLC and High Resolution Mass Spectrometer with Muitple Dissociation Techniques
Favorite
W0930-06-40 - Delayed Release Drug Products Behave Differently in Physiological Bicarbonate Buffer
Favorite
M1430-03-17 - Delivery of Heparin via Laser-Generated Micropores
Favorite
M0930-03-15 - Dendrimer-Based Antibiotics for the Treatment of Bacterial Biofilms
Favorite
M1030-03-20 - Dermal and Transdermal Delivery of Oxicams Using Deformable Liposomes
Favorite
T0930-03-17 - Dermal Rutin smartCrystals – Skin Friendly Commercial Concentrates for Anti-pollution Products
Favorite
M1430-07-48 - Dermal Wound Bandages Made from 3D Printed Poly-l-lactic Acid Mats Coated with Polyethylene Glycol and Loaded with Neomycin
Favorite
M0930-04-26 - Design and Characterization of a New Drug-Herb Isoniazid-Curcumin Cocrystal for Potentially Improving Tuberculosis Treatment
Favorite
T1030-04-27 - Design and Evaluation of Olaparib Nanostructured Lipid Carriers for Bioavailability Enhancement Toward Breast Cancer Treatment
Favorite
W1030-04-24 - Design and In Vitro Characterization of Lipid Carriers Loaded with Antiretroviral for Oral Drug Delivery
Favorite
M1530-02-09 - Design of a Two-Phase System for the Sustained Delivery of Growth Factors for Bone Tissue Engineering Applications
Favorite
M1330-05-35 - Design of Chewable Tablet Dosage Forms in Light of the New FDA Guidance
Favorite
T1130-04-27 - Design of Lipid-based Solid Dispersion Systems for Increasing Dissolution Rates of Celecoxib
Favorite
T1030-07-44 - Design of Surface Modified Liposomal Nanoparticles for Targeted Delivery of Gene to the Brain
Favorite
W1230-05-30 - Design of Ternary Amorphous Solid Dispersions Containing a High Viscosity Polymer and Mesoporous Silica by Hot Melt Extrusion to Produce a Heightened Parachute Effect During Dissolution
Favorite
W1130-07-44 - Design of Tubular Electrospun Grafts Containing Vancomycin for Vascular Tissue Regeneration
Favorite
M1230-01-07 - Design, Development, and In Vitro Characterization of a New 8-aminoquinoline Derivative Loaded Solid Lipid Nanoparticles for Relapsing Malaria
Favorite
M1030-07-46 - Design, Formulation, and In Vivo Evaluation of 3D Printed Dexamethasone Polypropeylene Fumarate (PPF) Biodegradable Stents for Vascular Applications
Favorite
M1030-02-11 - Design, Synthesis and Characterization of Biotinylated Polymeric Micelles to Combat Breast Cancer
Favorite
M1330-02-08 - Designing a Novel High Hydroxyl Oil-Based Polyol as a Drug Delivery Carrier
Favorite
T1230-06-41 - Detection of Host Cell Proteins (HCPs) in Biotherapeutics with Reproducible UHPLC and HRAM Orbitrap-Based MS
Favorite
M1130-06-41 - Detection of Silicon as a Process Impurity in Captisol® (Betadex Sulfobutyl Ether Sodium) by ICP-MS
Favorite
W0930-02-08 - Determination and Identification of Biomarkers for Normal and Diabetic Rats under Aerobic and Anaerobic Exercise
Favorite
M1230-07-46 - Determination of Betadex (β-Cyclodextrin) According to the USP Betadex Sulfobutyl Ether Sodium Monograph and Possible Improvements
Favorite
T1230-06-37 - Determination of Residual Hydroxylamine in Complex Formulations
Favorite
M1330-06-40 - Developing a Fast, Non-Destructive Terahertz Dissolution Assay of Tablets During Manufacture
Favorite
W1230-02-14 - Developing an Affinity-Based Subcutaneous Formulation for a GLP-1-Like Agonist
Favorite
T0930-07-44 - Developing an Oral Dissolving Film (ODF) Formulation of Microparticulate Gonorrhea Vaccine
Favorite
T1230-06-38 - Development and Application of Riboflavin and Diphenhydramine Impurity Solutions for Pharmacopeial Testing
Favorite
T1030-06-40 - Development and Application of USP Apparatus 4 for In Vitro Drug Release from Omega-3-Acid Ethyl Esters Capsules
Favorite
T1530-04-26 - Development and Characterisation of Ketoprofen-Benzocaine Deep Eutectic Mixtures
Favorite
M1530-04-26 - Development and Characterisation of Procaine-Ketoprofen Deep Eutectic Mixtures
Favorite
T1230-07-44 - Development and Characterization of 3D Printed Delayed-Release Orodispersible Film Loaded with Lansoprazole Drug
Favorite
M1230-01-05 - Development and Characterization of an In Situ Thermosensitive Electro-Responsive Nanogel-Composite for Controlled Release of a Bioactive Agent for Nose-to-Brain Delivery
Favorite
M1430-03-18 - Development and Characterization of Nanoparticulate Delivery System for the Treatment of Cutaneous Melanoma
Favorite
T1530-02-13 - Development and Characterization of Nanoparticulate Dosage Form to Deliver Anti-cancer Drug Carmustine Across the Blood-Brain Barrier
Favorite
M1530-01-04 - Development and Characterization of Orally Disintegrating Films Loaded with High Levels of Ibuprofen Nanoparticles
Favorite
T1330-02-12 - Development and Characterization of PLGA Nanoparticles for the Delivery of mitoNEET Ligand NL-1 in Stroke Treatment
Favorite
M1530-03-15 - Development and Characterization of Polymeric Films Containing Thymoquinone for the Treatment of Wound Healing and Bacterial Skin Infections
Favorite
W1030-07-49 - Development and Characterization of Sublingual Insulin Film
Favorite
T1230-03-20 - Development and Evaluation of a Micro-dispersed Drug-in-Adhesive Delivery System of 3-fluoroamphetamine
Favorite
T1230-03-21 - Development and Evaluation of Dermatological Formulation with Enhanced In Vitro Drug Release Using Reduced Level of Diclofenac Sodium
Favorite
T1230-01-06 - Development and Evaluation of Sorafenib-Loaded Nanoparticles as Inhalable Drug Delivery Carriers for Treatment of Non-Small Cell Lung Cancer
Favorite
T0930-05-34 - Development and Optimization of Fast Dissolving Buccal Films Loaded with Ketoprofen Nanoparticles Using Box-Behnken Design
Favorite
W1230-03-18 - Development and Optimization of Oil in PEG Cream
Favorite
W0930-07-46 - Development and Stability of an Extraction Resistant Drug Formulation Containing Crosslinked Poly(Acrylic Acid)
Favorite
W1130-06-40 - Development and Validation of a High-Performance Liquid Chromatography (HPLC) Method for the Determination of Formaldehyde and Acetaldehyde Content in Microcrystalline Cellulose Samples
Favorite
W0930-03-20 - Development and Validation of a Novel HPLC-UV Analytical Method and Stability Evaluation of 4-phenylbutyric Acid, an Antidote for Warfare Chemicals
Favorite
M1030-07-48 - Development and Validation of a Sensitive Method for Alkyl Sulfonate Genotoxic Impurities Determination using Gas Chromatography Coupled to Triple Quadrupole Mass Spectrometry
Favorite
T1530-06-38 - Development and Validation of Fast Stability indicating UPLC Method for Quantification of Pseudoephedrine, Dextromethorphan, Triprolidine,Guaifenesin and preservatives present in cough and cold syrups
Favorite
M1230-06-41 - Development and Validation of In Vitro Release Test (IVRT) Method for Ophthalmic Suspensions – A Walkthrough Exercising Regulatory Guidance
Favorite
T1330-06-38 - Development of a Comprehensive GC-MS Headspace Method for the Evaluation of Multiple Antimicrobial Preservatives in Peptide and Protein Formulations
Favorite
M1230-02-08 - Development of a Folate-Decorated, Macrophage-Targeting Nanoemulsion System for HIV Treatment
Favorite
M1130-01-03 - Development of a Functional Polymer with an Environmental pH Responsiveness for Cancer Targeting
Favorite
W1230-03-20 - Development of a Library of Plastics Additives for Identification of Extractables
Favorite
M1330-02-14 - Development of a Lipopolysaccharide Antagonist for the Systemic Treatment of Sepsis
Favorite
T1430-02-12 - Development of a Mechanistic Absorption Model to Bridge Late Stage Formulation for a BCS Class II Drug Candidate
Favorite
T1230-07-49 - Development of a Medicated Chewing Gum Containing
Sceletium tortuosum
and Process Optimization Utilizing the SeDeM Diagram
Favorite
W1130-07-47 - Development of a Method to Measure the Encapsulation Efficiency of Phenylalanine in Ethylcellulose Microcapsules and Its Use to Determine Efflux of Phenylalanine from the Microcapsules
Favorite
M0930-03-20 - Development of a Novel and Innovative Drug Delivery System for Local Targeting of the Esophagus
Favorite
T1030-07-47 - Development of a Novel In Vitro Model to Predict Risk of Skin-to-Skin Drug Transfer during Transdermal Hormonal Replacement Therapy
Favorite
M1530-07-44 - Development of a Packaging System for a Cell Therapy Product Suitable for Cryogenic Storage by Utilizing Residual Seal Force and Headspace Oxygen Content Analysis
Favorite
W0930-01-05 - Development of a Protein-Free Amphiphilic Lycopodium Spore Microcapsule for Oral Therapeutics Delivery
Favorite
W1230-04-28 - Development of a Solid Self-Emulsifying Drug Delivery System Containing Dutasteride
Favorite
W1030-04-26 - Development of a Solubilised Capsule Formulation Using Co-micronisation and Precipitation Inhibition
Favorite
T1130-05-34 - Development of a Sustained Release Orally Disintegrating Films for Tamsulosin Hydrochloride
Favorite
M1230-05-32 - Development of Abuse Deterrent Formulation for Loperamide Using Hot Melt Extrusion
Favorite
W1030-06-40 - Development of an GMP Automated Platform for API Forced Degradation Studies and Method Linearity
Favorite
W1230-06-38 - Development of an HPLC Method for the Identification of a Disaccharide Counter-ion in the DP Investigation on the Anomalous Behavior of the Disaccharide Standard Solution
Favorite
W1130-05-29 - Development of an In Situ Gel Formulation for the Enhanced Topical Delivery of Niacinamide on Microporated Skin
Favorite
M0930-01-05 - Development of an Inhaled Clofazimine Formulation for the Treatment of Pulmonary Tuberculosis
Favorite
M1230-03-18 - Development of an Ointment-Based Topical Ocular Delivery System for Hydrogen Sulfide
Favorite
M1130-02-13 - Development of Anti-inflammatory Drug-Eluting Polymeric Devices
Favorite
T1430-02-14 - Development of Aprepitant-loaded Phosphatidylcholine Solid Dispersions for Enhancing Dissolution Rates
Favorite
W1130-03-20 - Development of Carboplatin Loaded Liposomes for Pulmonary Delivery
Favorite
T1130-05-31 - Development of Different Density-Controlled Release 3D Printing Tablets Using HME Technologies
Favorite
T1030-01-05 - Development of Eudragit Based Natamycin Films for Ophthalmic Applications Using Design of Experiments Approach
Favorite
M1330-01-06 - Development of Excipient-Free Caveolin-1 Scaffolding Peptide Dry Powder Inhalation for Treatment of Idiopathic Pulmonary Fibrosis – Stability Study
Favorite
T1030-01-04 - Development of High Potency Tacrolimus Dry Powder for Inhalation by Thin Film Freezing
Favorite
T0930-03-16 - Development of Hyaluronidase Sensitive Palm Oil Based Organogel for In Vitro Release of HIV/AIDS Microbicides Using Artificial Neural Networks
Favorite
T1530-07-48 - Development of Implantable Malaria Chemoprophylaxis
Favorite
T1130-02-13 - Development of In Vitro - In Vivo Correlations (IVIVC) Using the Gastro-Intestinal Simulator (GIS)
Favorite
W0930-01-04 - Development of Inhalable Solid Lipid Nanoparticles Formulation by Hot Melt Extrusion Technique
Favorite
T1530-03-19 - Development of iRGD Conjugated Semifluorinated Nanoassemblies for Targeted Drug Delivery to Solid Tumors and Study of the Polymer Architecture Effect to the Delivery Platform
Favorite
M1130-04-22 - Development of Monoacetyldiglyceride (MADG) Loaded Self-emulsifying Granules with Enhanced Oral Bioavailability Using Fluid Bed Granulator
Favorite
M1430-04-27 - Development of Nano-amorphous Spray Dried Powder to Improve Dissolution Rate: Stabilizer Selection and Formulation Optimization Using Quality by Design (QbD) Approach
Favorite
W1030-03-15 - Development of Nanoparticles for the Treatment of Lymphatically Metastasizing Melanoma
Favorite
T1530-07-46 - Development of Novel Bilayer Microarray Patches (MAP) Containing a High Dose of Long-Acting Cabotegravir Nanosuspension as an Alternative to Injectable Delivery
Favorite
T1230-07-43 - Development of Novel Formulations Through 505(b)(2) Pathway Prevailing Over the Regulatory Barriers
Favorite
M0930-02-14 - Development of Oral Solid Dosage Form for Sunitinib Free Base with Improved pH-Dependent Dissolution Rate and Absorption
Favorite
T1530-03-21 - Development of Polyssacharide-Based Nanoparticles for Mucosal Vaccine Delivery Against Group A Streptococcus
Favorite
W1030-04-25 - Development of Rutin smartCrystals
®
for Targeted Dermal Application
Favorite
T1230-06-39 - Development of Solution Based Certified Reference Materials for the Analysis of Gabapentin Pharmaceutical Impurities
Favorite
T1130-07-48 - Development of Stability Indicating RP-HPLC Method for an Anthraquinone Botanical Extract in a Topical Formulation for Treatment of Wounds
Favorite
M1330-07-49 - Development of Supersaturable Solidified Self-nanoemulsifying Drug Delivery System to Enhance the Dissolution Rate of a Ketoprofen
Favorite
W0930-02-09 - Development of the Customized Cardiovascular Stent Made from the Biomimetic Hydrogel
Favorite
M1030-07-44 - Development of Transdermal Controlled Release Formulation for Tacrolimus
Favorite
M0930-03-19 - Development of Pediatric Anti-HIV Formulations with Improved Dissolution Characteristics
Favorite
M1430-05-29 - Dexlansoprazole Dual Delayed Release Formulation Using pH Dependent ECOPOL® Polymers
Favorite
M1030-04-22 - Diclofenac Sodium Entrapment Efficiency and Stability in MCM-41 Carrier Which Surface Had Been Amino-Functionalized Using Two Methods
Favorite
M1130-07-45 - Difference in Palatability Among the Formulations of Kremezin®, an Oral Absorbent of Uremic Toxins, in Chronic Kidney Disease (CKD) Patients
Favorite
W1230-02-08 - Different Liposome Classes Interact Differently with Brain Endothelial Cells
Favorite
T0930-06-42 - Differentiating the Effects of Different Oxidative Stress Conditions on Therapeutic Monoclonal Antibodies
Favorite
T1230-04-26 - Direct Powder Extrusion 3D Printing of Itraconazole-Hydroxypropylcellulose Formulations
Favorite
T1530-04-24 - Discovery and Characterization of Novel Solubilizing Excipients via High Throughput Methods
Favorite
M1030-06-37 - Dissolution Behavior of Neutral Drugs in FaSSIF Versions
Favorite
M1330-04-24 - Dissolution Mechanism of Amorphous Solid Dispersions as a Function of Drug Loading: Role of Polymer Hydrophobicity
Favorite
T1130-02-08 - Dissolution Methods for Evaluation of Oral Soluble Films: A Comparison Between USP-2 and a Novel “Basket-in-Tube” Method
Favorite
W0930-04-24 - Dissolution of Indomethacin Crystals into a Polymer Melt: Role of Diffusion and Fragmentation
Favorite
T0930-02-13 - Docetaxel Formulation in Polysorbate 80: A Complex and Sensitive System
Favorite
T1030-04-28 - Double-Layer Coated Solid Dispersion of Aprepitant (SYO-1906) for Enhancing Solubility and Bioavailability without Nanonization
Favorite
W1230-06-37 - Double-Layer Complex Tablets of Tadalafil and Amlodipime to Treat Erectile Dysfuncion and Hypertension
Favorite
W1230-01-06 - Downstream Process Considerations for Industrial Polymeric Submicron Particle Manufacturing
Favorite
M1430-07-49 - Drug Delivery from a Novel Fixed-dose ICS/LAMA/LABA MDI using Co-suspension Delivery Technology: Evidence of Consistency, Robustness, and Reliability
Favorite
M1330-01-03 - Drug Repositioning of Poorly Soluble Drug, Flubendazole via Metastable Salt Formation
Favorite
M1030-02-10 - Drug Supersaturation in Lipid-Based Drug Delivery Systems: Pharmacokinetic Studies with Celecoxib and Cinnarizine
Favorite
M1430-05-35 - Dry Powder Coating of a Novel Polymer for Taste Masking
Favorite
T1530-05-34 - Dry Powder Coating of Guaifenesin for Taste Masking in Orally Disintegrating Tablets
Favorite
T0930-01-02 - Dry Powder Formulation and Characterization of Potential Anti-Tuberculosis Drug CPZEN-45
Favorite
T1330-03-17 - Dry Powder Inhalation System for Non-Viral Gene Editing
Favorite
W0930-02-14 - Dual Functional Oleic Acid Magnetic Nanoparticles – In Vitro In Vivo Model for Glioblastoma Multiforme
Favorite
T1030-03-17 - Dual Neurovascular Targeting Platform for Stroke Based on Platelet-Like Nanoparticles Loaded with Ginkgolide B
Favorite
M1430-07-46 - ɑ
v
β
3
-Targeted Liposomal Drug Delivery System with Attenuated Immunogenicity Enabled by Novel Peptides for Glioma Therapy
Favorite
T0930-05-32 - Edible Pyrazinamide-Loaded Orodispersible Hollow-Cup Carrier for Flexible Paediatric Dosing: Design and In Vitro Physicochemical Characterization
Favorite
W1130-05-33 - Effect of % HPO and Particle Size Levels of Hypromellose on the Release of Theophylline Controlled Release Tablets – A Quality by Design (QbD) Approach
Favorite
M1330-05-32 - Effect of Binder Level on Structure and Properties of Acetaminophen-Klucel Granules Prepared Using Continuous Twin-Screw Melt Granulation
Favorite
T1030-05-33 - Effect of Binder Type and Addition Method on Granule Properties in Continuous Twin Screw Wet Granulation
Favorite
T0930-07-45 - Effect of Encapsulated Gas in Microbubbles on Ultrasound-based Drug Delivery for Brain
Favorite
M1330-03-21 - Effect of Ethylene Oxide External Surface Sterilization on Stability of Ranibizumab in Prefilled Syringes
Favorite
M1130-05-34 - Effect of Excipients as Physical and/or Chemical Barriers on Abuse-Deterrent Extended Release Tablet
Favorite
M1230-07-49 - Effect of Formulation and Printing Parameters on Critical Quality Attributes of Printlets Printed by Selective Laser Sintering
Favorite
W1130-01-02 - Effect of Formulation Factors on Stability of Aqueous Solution Containing Pemetrexed
Favorite
M1030-01-05 - Effect of Formulation Variables on IOP Lowering Profiles of Delta
9
-Tetrahydrocannabinol Valine Hemisuccinate Loaded Nanoemulsion in Normotensive Rabbits
Favorite
T1130-03-19 - Effect of Incremental Changes in Surfactant of Semi-solid Topical Product and Its Effect on Performance Attribute
Favorite
T1230-05-35 - Effect of Magnesium Stearate Hydrate Form on Dissolution
Favorite
M1230-05-30 - Effect of Manufacturing Process Parameters on Mechanical Characteristics of Megabeads
Favorite
M1530-03-21 - Effect of Mixing Method as a Processing Parameter on the Adhesive Properties of Suspension-Based Transdermal Patches
Favorite
M1430-06-40 - Effect of Oxygen Level and Temperature on Stability of Lipids
Favorite
T1130-04-28 - Effect of Particle Morphology on the Mechanical Properties of Felodipine in PVP VA64 Spray-Dried Amorphous Solid Dispersions
Favorite
T1430-05-30 - Effect of PEG 400 and Polyvinyl Alcohol (PVA) on the pH-Sensitive Nanoparticles Formation and Stability
Favorite
T0930-06-36 - Effect of Permeation Enhancers on Insulin Solution via Sublingual Administration
Favorite
M1030-01-04 - Effect of pH on the Degradation Rate of Tacrolimus in Cyclodextrin Solution
Favorite
W1230-05-29 - Effect of pH-Modifiers on Solubility and Dissolution Rate of Telmisartan Solid Dispersions by Hot Melt Extrusion Technology
Favorite
M0930-05-30 - Effect of Polymer and Drug Loading on the Drug Release Profile and Solid-State Stability of Anti-Solvent Precipitated Lumefantrine Amorphous Solid Dispersions
Favorite
W1130-01-05 - Effect of Polymer Source Variation on In Vitro Drug Release of Leuprolide Acetate Microspheres
Favorite
M1430-02-13 - Effect of Preparation Temperature and Pore Former on PLGA Microparticles
Favorite
M1330-01-02 - Effect of Salt Form on AR-13503 Polymer System Compatibility and In Vitro Release Kinetics
Favorite
T1330-05-29 - Effect of Solvent on Re-crystallization of BCS Class II Drugs during Strip Film Manufacturing via Solution Casting
Favorite
T1130-01-04 - Effect of Stabilizer on Thermal Stability of Cediranib Maleate/Cyclodextrin Complexes in Aqueous Suspension
Favorite
T1030-05-32 - Effect of Sugar and PEG on Helix Stabilization of Alanine Based Peptides
Favorite
M1130-01-04 - Effect of Surfactant and Surface Coating Material on the Physicochemical Properties of Pimozide Nanoparticles
Favorite
T0930-03-20 - Effect of the Addition of Sodium Chloride and Sodium Citrate in Some Attributes of Soft Gelatin Capsules
Favorite
T1030-05-31 - Effects of Binder and Concentration of Polyethylene Oxide on the Mechanical Properties of Abuse Deterrent Formulations
Favorite
W1130-02-11 - Effects of Co-solvents on the Properties of Goserelin-Loaded PLGA Microsphere
Favorite
W1130-04-27 - Effects of Drying Temperature and Particle Size Control on Downstream Performance of Spray Dried Regorafenib/HPMCAS System Dissolved in Tetrahydrofuran (THF)
Favorite
W1030-02-13 - Effects of Fatty Acid Composition in Polysorbate on Biotechnology Drug Product Quality
Favorite
T1330-04-28 - Effects of Labrasol and Its Related Formulations on the Intestinal Absorption of Insulin and Elucidation of Their Absorption Enhancing Mechanisms
Favorite
W1030-07-43 - Effects of Microstructure on Lidocaine-Prilocaine Topical Product Performance
Favorite
T1130-05-33 - Effects of Processing and Formulation Variables on the Abuse-Deterrent Properties of PEO-Matrix Tablets
Favorite
M1430-07-47 - Effects of Sugar Blending on Mechanical Properties of the Dissolving Microneedles
Favorite
T1330-07-48 - Effects of Synthesis Parameters on Formation and Property of Thermo-Responsive Injectable Hydrogel Scaffolds for Stem Cell Engineering
Favorite
W0930-04-23 - Effects of Temperature and Ionic Strength of Dissolution Medium on Charge-Assisted Bond N
+
-H Mediated Gelation of Amorphous Lurasidone Hydrochloride
Favorite
W1130-01-04 - Efficacy of Ethanol Injection as a Low Temperature, Mechanical Shear Stress-free Method to Prepare Docetaxel-Folate-Targeted Liposomes
Favorite
M1130-02-14 - Efficient Cell Growth Inhibition Using Interferon-β pDNA Complexes of a Novel Phosphorylcholine-Based Polymer for Glioblastoma Therapy
Favorite
T0930-02-12 - Efficient Nanog Knockdown by Novel Ternary siRNA Complexes for Acute Myeloid Leukemia Therapy
Favorite
T1530-07-47 - Engineering 3d Printed Non-Viral Gene Delivery System for Bone Regeneration
Favorite
M1430-02-09 - Engineering of Piroxicam Loaded Polymer Hybrid Microspheres: Development, Characterization and In Vivo Evaluation
Favorite
T1330-04-25 - Enhanced Dissolution of Ibuprofen by Nonpareil Beads Containing Solubility Enhancers
Favorite
M1230-04-24 - Enhanced Oral Bioavailability of Paclitaxel by Self-Microemulsifying Drug Delivery System: Formulation Development, In Vitro and In Vivo Evaluation in Rabbits
Favorite
T1530-03-16 - Enhanced Subcellular Trafficking of Resveratrol Using Mitochondriotropic Liposomes in Cancer Cells
Favorite
T0930-07-47 - Enhanced Topical Delivery by a Microcurrent Generating Device
Favorite
T1130-03-17 - Enhanced Transdermal Delivery of 4-Phenylbutyric Acid– A Chemical Chaperon Effective Against Vesicant Warfare Chemicals
Favorite
M1230-04-26 - Enhancement of Aqueous solubility of Hispolon by Complexation with Sulfobutylether-β-Cyclodextrin
Favorite
W1230-03-17 - Enhancing the Delivery of Ibuprofen Through the Skin Using In Silico Modeling
Favorite
M1130-04-24 - Enhancing the Intestinal Permeability of Fenretinide Using Milk Derived Exosomes
Favorite
W1130-02-12 - Estimating Excipient Effect on Dissolution Profiles of Solid Solutions Using DDDPlus
TM
Favorite
M1130-07-49 - Eutectic Mixtures of Celecoxib with Adipic Acid/Saccharin: Improved Dissolution Rate and Wettability
Favorite
M0930-01-03 - Evaluating the Batch to Batch Reproducibility and Aerosol Performance of Spray Dried Albuterol Sulfate Formulations Using Cascade Impaction and Laser Diffraction Methods
Favorite
M1130-07-44 - Evaluating the Potential of Drug Eluting Contact Lenses for Treatment of Bacterial Keratitis Using an Ex Vivo Corneal Model
Favorite
M1130-05-32 - Evaluation of a New Grade of Highly-Compressible Methylcellullose for Direct Compression
Favorite
T1330-06-41 - Evaluation of an Automated, Acidic pH Protein Digestion for Reduced Levels of Artificial Deamidation in Biotherapeutic Peptide Mapping Studies
Favorite
M1530-07-48 - Evaluation of an Immediate-Release Formulation of Hydroxychloroquine Sulfate with an Interwoven Pediatric Taste-Masking System
Favorite
M1230-06-37 - Evaluation of Degradation Products of Insulin using High Resolution Mass Spectrometry with Proteome Discoverer and BioPharma Finder
Favorite
M1030-07-45 - Evaluation of Different Suppliers of Ethylene Vinyl Acetate Used in Intravaginal Rings
Favorite
T1530-04-28 - Evaluation of Distribution and Anticancer Activity of Conformational Switch-Based, pH-Sensitive Liposomes in 3D Multicellular Spheroids
Favorite
M1030-05-33 - Evaluation of Hot Melt Extruded Caffeine Pellets Containing POLYOX™ Water Soluble Resins
Favorite
T1430-06-39 - Evaluation of Influence of Pediatric Gastrointestinal Fluid Composition and Volume on Dissolution and Solubility of BCS II Drug
Favorite
W1130-05-32 - Evaluation of Instacoat CFC Formulation (Sugar Free) Using Chewing Gums
Favorite
W0930-05-32 - Evaluation of Instanute MB II, a Label Friendly High Solids Moisture Barrier Film Coating Formulation on Multivitamin Multimineral Tablets
Favorite
T0930-02-11 - Evaluation of Lansoprazole Enteric Hard Capsule Encapsulated by Sodium Alginic Acid
Favorite
W1130-02-10 - Evaluation of Metformin Tablet Using Wet granulation for Sustained Release
Favorite
T0930-03-19 - Evaluation of Metronidazole Bioavailability from Dermal Products Using an In Vitro Permeation Test (IVPT) Across Human Skin
Favorite
T0930-05-29 - Evaluation of Partially Pregelatinized Starch in a Continuous High Shear Wet Granulation Process
Favorite
T1330-03-20 - Evaluation of Quantitative Capsule Rupture Test Methods and Data Variability in Generic Omega-3 Capsule Applications
Favorite
T1430-05-35 - Evaluation of Taste Masking Efficiency of Kollicoat® Smartseal 100P Using Hot Melt Extrusion Techniques
Favorite
W1030-05-32 - Evaluation of Xanthan/ Locust bean blend Fluid Gels as Modified Release Oral Liquids
Favorite
T1430-03-17 - Ex Vivo Transport Study on Quercetin−Cyclodextrin Inclusion Complexes as Candidates for Nose−to−Brain Delivery
Favorite
M0930-02-08 - Excipient Similarity in Generic Formulations Containing Biopharmaceutics Classification System 3 Drugs
Favorite
M1130-02-10 - Exploitation of Coarse Black Phosphorus Using Plug-and-Play Technique for Inducing Chemo-Photo-Immunotherapy Against Colorectal Cancer
Favorite
M1530-04-22 - Exploratory Study of Aripiprazole-Adipic Acid Co-crystals by Hot Melt Extrusion Technique for Improved Solubility and Dissolution Rate
Favorite
M0930-06-40 - Exploratory In Vitro Mastication to Assess the Potential Accelerated Release of Fentanyl from a Transdermal Patch
Favorite
W0930-06-37 - Exploring Factors Affecting Nifedipine Biphasic Dissolution Profile Using an inForm Platform
Favorite
T1030-04-25 - Exploring Precipitation Inhibitors in Supersaturated Lipid-Based Formulations: Case Study Venetoclax
Favorite
T1230-05-31 - Exploring the Development of an Anhydrous Substitute for Petrolatum
Favorite
T1130-06-42 - Exploring the Physical Stability of Amorphous Drugs - The Thermodynamic Toolbox
Favorite
T0930-05-31 - Exploring the Role of Synbiotics as Carrier to Solidify Self Nano-emulsifying Drug Delivery System
Favorite
M1230-01-02 - Extending Shelf-Life of Therapeutic Proteins, Part 1: Arresting Rate of Aggregation during Agitation and Thermal Stress Using IgG as a Model Protein
Favorite
T1230-01-02 - Extending Shelf-Life of Therapeutic Proteins, Part 2: Reverting Reversible Aggregates into Monomers and Arresting Rate of Aggregation of Bevacizumab
Favorite
M1530-07-47 - Extractable Assessment of Blood Glucose Test Strips and Lancing Devices
Favorite
T1430-07-47 - Extremely Low Molar Ratio Captisol-Enabled Kidney Protective Iohexol Formulations – Comparative Cardiovascular Assessment in Anesthetized Male Dogs following Rapid Intracoronary Injection
Favorite
W1030-05-34 - Fabrication of Immediate Release Tablets via Fused Deposition Modeling 3D Printing Paired with Hot-Melt Extrusion
Favorite
W1130-07-49 - Fabrication of Shell-Core Delayed Release Tablet Using Dual Nozzle Fused Deposition Modeling 3D Printing Techniques
Favorite
T1530-01-07 - Factors of Bitterness in Clinical Medicines for Pediatric Patients Evaluated by Correlation between Physicochemical Properties or Biopharmaceutics Classification and Taste Sensor Responses
Favorite
T1030-06-39 - Factors to Consider During Filter Validation in Pharmaceutical QC
Favorite
M1130-04-25 - Fasted and Fed Bioequivalence Studies of SYO-1644 (Sorafenib Bioavailability Enhanced Tablets) in Beagle Dogs
Favorite
M1130-07-43 - FDA Draft Guidance, Use of Liquids and/or Soft Foods as Vehicles for Drug Administration – Why are Composition and Physicochemical Properties Important for Compatibility and Suitability Studies?
Favorite
T0930-03-18 - Film Forming Polymeric Solutions as Drug Delivery Systems for the Transdermal Delivery of Drugs
Favorite
T1230-05-30 - Fine Engineered Excipients for Improving the Disintegration and Dissolution Behaviors for BCS II Drugs
Favorite
W1130-07-46 - FITC Dextran Loaded PLGA Microneedles for Its Application in Transdermal Drug Delivery
Favorite
M1130-05-29 - Flow Behavior of the Cross-Linked Acrylic Acid Polymers Commonly Used in the Pharmaceutical Dosage Forms
Favorite
T1130-05-32 - Fluid Bed Coating of Microparticles: Effects of MicroCoat Technology on Drug Release
Favorite
T1530-06-39 - Fluoride in OTC Products by Ion Chromatography
Favorite
M1530-03-18 - FMX101 4% Topical Minocycline Foam: Drug Delivery into the Pilosebaceous Follicles, Sebum Softening Effect and Bacterial Susceptibility
Favorite
T0930-03-21 - Formation of Kollidon® VA-64 Based Theophylline Nicotinamide Co-crystals Utilizing Hot Melt Extrusion Technology
Favorite
M1230-03-21 - Formulating Pediatric Taste Masked Multiparticulates Using CPS
TM
Technology
Favorite
M1430-01-01 - Formulating Aerodynamically Equivalent pMDIs for Determining the Effect of Non-volatile Excipients on Aerosol Particle Dissolution
Favorite
M1530-02-13 - Formulation and Characterization of a Degradable Drug Eluting Implant Coating for Improved Osseointegration
Favorite
W0930-01-03 - Formulation and Characterization of Intranasal Microemulsions of Mebendazole: An Alternative Approach for Glioblastoma Multiforme Treatment
Favorite
W0930-03-19 - Formulation and Characterization of Nanostructured Lipid Carriers Containing Rivastigmine Hydrogen Tartarate for the Management of Alzheimer’s Disease
Favorite
M1230-02-11 - Formulation and Evaluation of Afatinib Loaded PLGA Nanoparticles for Metastatic Non-Small Cell Lung Cancer
Favorite
M1030-04-27 - Formulation and In Vitro Evaluation of Self Microemulsifying Drug Delivery System (SMEDDS) for Oral Delivery of Plumbagin
Favorite
T1430-01-05 - Formulation and Optimization of Delta 9 -Tetrahydrocannabinol- Valine-Hemisuccinate (THC-VHS, NB1111) Loaded Nanoemulsion
Favorite
W1030-02-11 - Formulation and Pharmacokinetic Study of Ibuprofen Nanoformulations
Favorite
W1230-07-49 - Formulation by Design
®
: A Novel Lego Approach for Predictable In Vivo Pharmacokinetic Profile Using 3D Printing Technology
Favorite
M1430-01-03 - Formulation Development and Characterization of Paclitaxel Loaded Nanostructured Lipid Carriers for the Treatment of Retinoblastoma
Favorite
M1230-04-23 - Formulation Development and Cytotoxicity Evaluation of Self-Emulsifying Drug Delivery System (SEDDS) containing Long-Chain Fatty Acid for Oral Delivery of Poorly-Soluble Drugs
Favorite
T1030-02-13 - Formulation Development for a Labile Bi-specific Protein
Favorite
M1430-04-24 - Formulation Development of Amorphous Solid Dispersions by Hot Melt Extrusion for a Poorly Soluble Calcium Channel Blocker
Favorite
M1330-07-45 - Formulation Development of Curcumin-Piperine Solid Dispersion via Hot-Melt Extrusion to Enhance Solubility and Bioavailability of Curcumin
Favorite
T1330-05-32 - Formulation Development of Fenofibrate Using Twin Screw Melt Granulation
Favorite
T1430-01-07 - Formulation Development, Optimization and Characterization of a Fluoroquinolone Antibiotic Loaded Nano-lipid Carriers for Ocular Applications
Favorite
M1530-05-29 - Formulation of a Metoprolol Succinate Extended Release Tablet with INSTAMODEL® Blend
Favorite
T1430-05-32 - Formulation of a Modified Release Dipyridamole Product, Equivalent to Reference Listed Drug (RLD) Aggrenox from Boehringer Ingelheim Using Tartaric Acid Pellets
Favorite
M1430-03-15 - Formulation of Acyclovir and Lidocaine Topical Gels for Herpes Simplex Virus Infections
Favorite
M1230-05-29 - Formulation of Glimepiride Immediate Release for Anti-diabetes Bilayer Tablets Using Design of Experiments
Favorite
M0930-07-46 - Formulation of Lipid Multi-Particulates – Part 1: Evaluation of Melt-Spray Congealing and Direct Injection for Targeted Product Profile Using Science and Engineering Approach
Favorite
T0930-05-30 - Formulation of Megabeads: A Novel Oral Dosage Form
Favorite
W1230-04-23 - Formulation of Peptide Loaded Layer-by-Layer Nanoparticles Targeting PepT1 Intestinal Transporters: A New Strategy for Oral Peptide Delivery
Favorite
W1230-01-07 - Formulation of Rivastigmine, a Liquid Drug Substance, for Use in Hollow Microstructured Transdermal Delivery System
Favorite
T1330-05-30 - Formulation, Evaluation, and Improvement of Meloxicam Oral Disintegrated Tablets Using Design Expert
®
and Six Sigma
Favorite
T0930-07-43 - Formulation, Evaluation, and Pharmacokinetic Study for Telmisartan Cubosomal Based Oral Tablet in Rabbits
Favorite
T1530-05-30 - Formulation, Evaluation, and Pharmacokinetic Study for Telmisartan Proniosomal Based Oral Tablet in Rabbits
Favorite
M1130-06-42 - Free siRNA Quantitative Analysis Method Development by Size Exclusion Chromatography (SEC)
Favorite
T1130-07-44 - Fully Automated Determination of pH Using Flow Cell Technology
Favorite
M1530-04-25 - Fundamental Evaluation and Characterization of Etoricoxib Solid Dispersions Prepared by Spray Drying
Favorite
W1130-04-24 - Gastrointestinal Stability of Solubility-Enhanced Ezetimibe and Simvastatin Formulations
Favorite
W1230-04-26 - Gelucire 48/16
®
for Type-IV Lipid Based Formulations and Their In Vitro In Vivo Performance Evaluation
Favorite
M1030-03-18 - Glabridin smartLipids for Skin Whitening Products – Optimization of Formulation and Production Parameters
Favorite
W1230-07-44 - Glucose Transporter -1 Targeting Liposomal Nanoparticles for Efficient Gene Delivery Across In Vitro Triple Co-Culture Blood Brain Barrier Model
Favorite
W0930-01-06 - Gold-Nanoparticles Coated with the Antimicrobial Peptide ε-Polylysine Dry Powders as an Inhalable Strategy for Local Therapy of Pulmonary Infection
Favorite
M1230-02-13 - Heparin-based IL-12 Complex Coacervate Inhibits B16F10 Melanoma Tumor Progression
Favorite
W1230-02-09 - High Throughput Manufacture of Doxorubicin Loaded PEGylated Liposomes
Favorite
T1430-01-03 - High-Density Lipoprotein Nanoparticles Delivering Liver X Receptors Agonist for the Treatment of Age-related Macular Degeneration
Favorite
W1130-03-16 - High-Throughput 3D Bioprinting of Corneal Equivalents for a Realistic Blinking Eye Perfusion Model
Favorite
T1430-04-26 - High-Throughput Formulation Screening to Enable Early Discovery Activities for Poorly Soluble Compounds
Favorite
W1030-06-38 - Holistic Analytical Characterization of Residual Host Cell Protein Impurities in Pharmaceutical Process Development toward a Knowledge-Based Risk Control Strategy
Favorite
T1030-02-08 - How Broadly Can Poly(urethane)-Based Implants be Applied to Drugs of Varied Properties?
Favorite
M1030-04-26 - How to Enhance the Intestinal Permeability of the Peptide Leuprorelin?
Favorite
W0930-02-10 - HPC Molecular Weight Impact on the Drug Solubility of Dry Nano-Suspensions
Favorite
T1030-07-48 - HPMCAS-based Amorphous Solid Dispersion containing Surfactant Prepared via Hot-melt Extrusion: Effects of Different HPMCAS grades and Particle Size of Extrudates on Drug Release and Supersaturation
Favorite
T1330-06-42 - HR Multi-Attribute Method for Critical Quality Attribute Monitoring and New Peak Detection
Favorite
M1530-02-11 - Human Serum Albumin: Drug Delivery Template Targeting Breast Cancer Cells
Favorite
T1230-02-10 - Hyaluronic Acid Modified Mesoporous Titania Nanoparticles for Target Delivery of Doxorubicin
Favorite
M1030-02-09 - Hyaluronic Acid Targeted, Dual Drug Loaded, Mixed Nanomicelles for the Treatment of Breast Cancer
Favorite
W1130-04-22 - α- tocopherol Loaded PLGA Nanoparticles for the Treatment of Spinal Cord Injury
Favorite
T1130-02-11 - Identification of a Clinically Relevant Dissolution Method of EGb 761 Tablet for Better Correlation with Its In Vivo Pharmacokinetics
Favorite
W1130-06-38 - Identification of Extractables and Leachables from Pharmaceutical Containers by Raman Microscopy
Favorite
T1430-02-09 - Identification of Potential Formation Causes of Adverse Effects Caused by Tablet Product Brand-Switching of Warfarin Using PBPK/PD Modeling
Favorite
W1030-01-04 - Illustrative and Predictive Tools: Isothermal Calorimetry Combined with Molecular Modelling for the Study of Cyclodextrin/Drug Interactions
Favorite
T1030-04-24 - Imidazole-Based pH-Sensitive Convertible Liposomes - Turning Stealth Liposomes into Cationic Liposomes for Anticancer Drug Delivery
Favorite
M1430-03-20 - Impact of Critical Formulation Variables on a Nano-Lipid Cannabidiol Formulation
Favorite
T1230-04-27 - Impact of Drug Loading on Compaction Properties of Itraconazole-PVPVA Amorphous Solid Dispersions
Favorite
T1430-03-20 - Impact of Drug-Polymer Hydrogen Bonding Interaction on the Initial Drug and Polymer Release from Tableted Amorphous Solid Dispersions
Favorite
W1130-05-31 - Impact of Formulation Components on Physical Properties of Mini-tablets
Favorite
T1430-02-11 - Impact of HPC Chain Length on the Supersaturation of Itraconazole
Favorite
T1230-04-23 - Impact of Incorporated APIs on Material Properties of Hot-Melt Extruded Amorphous Solid Dispersions
Favorite
W1130-01-06 - Impact of Manufacturing Processes on Critical Quality Attributes of Brinzolamide Ophthalmic Suspensions
Favorite
M0930-05-31 - Impact of Milling on the Evaluation of Abuse-Deterrent Formulations
Favorite
M1330-04-25 - Impact of Polymeric Carriers on the Processability of Theophylline Nicotinamide Pharmaceutical Co-crystals Utilizing Hot Melt Extrusion Technology
Favorite
W1030-05-29 - Improved Extended Release Highly Loaded Drug Compositions Using Carbopol
®
Polymers in Combination with Suitable Microenvironmental pH Modulators
Favorite
T1530-06-42 - Improved Middle-Down Characterization of Antibodies Using Multiple Ion Activation Techniques and Proton Transfer Reaction on a Modified Orbitrap Mass Spectrometer
Favorite
M1530-06-40 - Improved Osmium Recovery for USP < 232 > Assessments
Favorite
M1530-03-20 - Improvement of In Vitro Skin Penetration Method via Modified Skin Penetration Model (MSPM)
Favorite
M1330-04-22 - Improving Mechanical Properties of Crystalline β-Mannitol by Cocrystallization with Calcium Chloride
Favorite
M1130-04-28 - Improving Oral Drug Absorption – Which Technology to Select? A Spray-Dried Dispersion and Lipid-Based Formulation Case Study Using Abiraterone Acetate
Favorite
M1130-03-15 - Improving Side Effect and Efficiency of Omeprazole Using Oral Thin Film In Vitro Evaluation
Favorite
W1130-04-26 - Improving Solubility and Oral Bioavailability of a Novel Anti-malarial Prodrug: Comparing Spray-Dried Dispersions with Self-emulsifying Drug Delivery Systems
Favorite
W1230-04-27 - Improving the Aqueous Dissolution Behavior of Ursolic Acid and Curcumin Utilizing an Enhanced Amorphous Solid Dispersion Technique
Favorite
M1530-04-23 - In Situ Crystal Growth Rate Distributions Enabled by Single Particle Tracking
Favorite
W1030-01-01 - In Situ Crystallisation of Propranolol Salts in an Amorphous Polymeric Matrix Made of Soluplus®
Favorite
T1430-01-04 - In Situ Gel of Cyclosporine a Loaded Solid Lipid Nanoparticles for Topical Occular Delivery in Dry Eye Disease
Favorite
T1430-02-08 - In Situ Rheological Measurements of the Gellan Gum Fluid Gel
Favorite
T1530-05-32 - In Situ Stablisation of Fluid-Bed Coating Process of Sustained Release Microparticles: Reduction in Particle Cohesion
Favorite
W1030-01-02 - In Vitro µFlux Studies to Understand the Impact of HPßCD Concentration on Exposure in Rat Species
Favorite
T1230-03-15 - In Vitro and Ex Vivo Stability and Permeation of Acetylsalicylic Acid (Aspirin®) in View of Its Nose-to-Brain Delivery in CNS Disorders and Cancer
Favorite
M1130-03-18 - In Vitro and In Vivo Assessment of a Novel Immediate Release Abuse Deterrent Dextroamphetamine Formulation
Favorite
W1230-05-32 - In Vitro and In Vivo Assessment of the Potential of Supersaturation to Enhance the Absorption of Poorly Soluble Basic Drugs
Favorite
T1130-03-18 - In Vitro and In Vivo Evaluation of Transdermal Absorption of Solifenacin Succinate in Cream and Tape Formulations
Favorite
W1130-01-01 - In Vitro and In Vivo Evaluation of PLGA In Situ Implant and Nanoparticles Sustained Injectable Formulations of Entecavir
Favorite
M1530-02-14 - In Vitro Anti-cancer Evaluation of Paclitaxel/Alpinumisoflavone Co-loaded Micelles
Favorite
M1530-03-17 - In Vitro Artificial Multilayer Skin Model to Study Rate of Drug Transport
Favorite
M1230-07-45 - In Vitro Assessments of Nasal Discomfort Caused by Abuse Deterrent Formulations
Favorite
T1430-06-40 - In Vitro Biphasic Dissolution Test: A Study of Excipient and Manufacturing Variables
Favorite
T1030-03-15 - In Vitro Characterization and Targeted Delivery of Hydroxyethyl Starch-Polyethyleneimine Based Polyplexes Using a Transferrin Receptor Antibody (8D3)
Favorite
W1030-04-28 - In Vitro Dissolution and Pharmacokinetic Studies of Aceclofenac Immediate Release Tablets Incorporating Its Inclusion Complex with Hydroxypropyl-β-Cyclodextrin
Favorite
T1430-06-37 - In Vitro Dissolution of a Weak Basic Drug in Standard Biorelevant Media and Media Representing PPI Co-administration
Favorite
T1430-07-46 - In Vitro Evaluation and Stability of the Deterrence Performance of Dextromethorphan HBr-AcDiSol
®
Complex Tablets
Favorite
T1030-04-23 - In Vitro Evaluation of Leuprolide-Containing Solid Lipid-Based Nanosuspensions: Ability to Encapsulate, Release, Protect, and Permeate in the Gastrointestinal Tract
Favorite
M1130-07-48 - In Vitro Investigation of Regional Nasal Drug Delivery using Two Glucocorticoid Nasal Spray Products and Twenty Anatomical Nasal Replicas
Favorite
M0930-07-49 - In Vitro Micro-dissolution Testing as an Efficient Predictive Tool for the Development of Suspension Type Lipid-Based Formulations
Favorite
M0930-06-41 - In Vitro Release Testing of PLGA Nanoparticles Using Flow-Through Cell USP-4 Apparatus
Favorite
T1330-07-49 - In Vitro, Ex Vivo, In Vivo Studies of Insulin Permeability Enhancement by the Use of Microcontainers
Favorite
T1330-03-15 - In Vitro and In Vivo Studies of Dibenzoylmethane (Hydrophobic) and Oxytocin (Hydrophilic) Formulations for Intranasal Delivery
Favorite
M1430-01-05 - In Vivo and Ocular Pharmacokinetic Evaluations of Ophthalmic Gelling Formulations Containing Natamycin Loaded PEGylated Nanolipid Carriers
Favorite
T1030-06-36 - In Vivo Drug Dissolution in Human Oral Cavity from Orally Disintegrating Tablet and Comparability with In Vitro
Favorite
T0930-01-05 - In Vivo Evaluation of Inhalable Sildenafil Citrate-Loaded Hydrogel Microparticles in Comparison to Orally Administered Viagra
®
for the Treatment of Pulmonary Arterial Hypertension
Favorite
T1430-07-45 - In Vivo Modulation of Dendritic Cells by a Dual Nanogel System for Immunotherapeutic Treatments
Favorite
W1230-02-13 - Incorporation of a Well Absorbed Marker Compound to Help Understand the Absorption of a Macromolecule from Oral Solid Dosage Forms
Favorite
T1430-01-02 - In-Depth Characterization of Novel Long-Acting Glaucoma Eye Drops
Favorite
W1130-06-36 - Individual p
K
a
Values of Aminoglycosides Determined by Multinuclear NMR Spectroscopy
Favorite
W1230-02-11 - Induction of Apoptosis by Doxorubicin Conjugated to Gelatin and Comparison to Unconjugated Doxorubicin in Human Breast Cancer Cells
Favorite
M0930-04-24 - Influence of Hydrate Form on the Preparation of Carbamazepine Amorphous Solid Dispersions by Hot Melt Extrusion
Favorite
T1530-04-25 - Influence of Milling Process on Hot Melt Extruded Amorphous Solid Dispersion
Favorite
M1430-05-30 - Influence of Poloxamer on the Dissolution and Stability of Hot Melt Extrusion Based Amorphous Solid Dispersion Using Design of Experiments (DoE)
Favorite
W1030-07-45 - Influence of Relative Humidity on Time to Break Analysis of Pharmaceutical Foams
Favorite
M1130-03-16 - Inhibition of Indomethacin Nucleation and Crystal Growth by Polymers from Supersaturated Solutions
Favorite
T1330-03-16 - Inhibition of Indomethacin Nucleation and Crystal Growth by Polymers from Supersaturated Solutions
Favorite
T1230-02-08 - Injectable In Situ Gelling Metronidazole System for Treating Jawbone Infections
Favorite
M1330-02-12 - Injectable Poly(lactic Acid) Core-Shell Structured Microspheres for 3-6 Month Controlled Release of Etonogestrel
Favorite
M1330-06-42 - In-Line Monitoring of Biocompatible Polymer Film Thickness via Near-IR Spectroscopy
Favorite
M1330-06-41 - In-line Monitoring of Critical Quality Attributes (CQAs) of Thin Drug-loaded Films via Raman Spectroscopy
Favorite
W1130-02-14 - Insight into Molecular Mechanisms Governing the High Concentration Behaviors of a Bispecific Antibody
Favorite
M0930-05-34 - Insights into the Thermal Properties and Freeze-Drying of Hydroxypropyl-beta-Cyclodextrin Formulations
Favorite
T1030-06-38 - Integrating Lattice Boltzmann and Bonded Particle Models to Simulate Tablet Disintegration and Dissolution
Favorite
W1130-06-42 - Intelligent Peak Deconvolution Analysis for Photodiode Array Detector
Favorite
M1430-06-37 - Interaction Between DKP Cyclization and Maillard Reactions in Quinapril Tablets
Favorite
T1030-01-03 - Intraocular Delivery of Triamcinolone Acetonide Protransfersome Gel by Trans-Eyelid Application for Improved Delivery
Favorite
T1330-06-40 - Introduction of a Novel Labelling Strategy to Facilitate LC-MS Analysis of Released
N
-glycans
Favorite
M1130-05-35 - Investigating role of Lactose particle size, disintegrant concentration & Manufacturing method on the finished product performance of selected BCS class I & IV drug
Favorite
W1130-06-37 - Investigating Species-Dependent Surface Properties of Albumins Using Inverse Gas Chromatography
Favorite
W1230-01-05 - Investigating the Effect of Protein-Excipient Ratios on Lyophile Stability and Robustness
Favorite
M1230-03-20 - Investigating the pH-dependent dissolution behavior of ketoconazole using a microscale medium/pH-shift
in vitro
model
Favorite
W0930-06-39 - Investigating the Release of Ibuprofen from Three Nurofen® Formulations Using the Dynamic Gastric Model (DGM)
Favorite
T1430-05-31 - Investigating the Tunability of Poloxamer 407 and Poloxamer 338 Gels
Favorite
T1030-05-34 - Investigation of Different Viscosity Grade Polymers for Development of Hot Melt Extruded Filaments for 3D Printing
Favorite
T1130-04-22 - Investigation of Dissolution Performance of Itraconazole Amorphous Solid Dispersions Using HPMCAS -L, -M and -H Grades
Favorite
M1430-05-34 - Investigation of Ion Exchange Resin Complexation Approach for Pediatric Dosage Form of Non-Ionic Drug
Favorite
M0930-01-02 - Investigation of Pharmacokinetic Sensitivity to Regional Lung Deposition of Locally-Acting Orally Inhaled Drug Products
Favorite
M1430-04-26 - Investigation of Possible Solubility and Dissolution Advantages of Cocrystals: Aqueous Solubility and Dissolution Rates of Ketoconazole and its Cocrystals as Functions of pH
Favorite
W0930-05-34 - Investigation of the Solubility Enhancement Potential of Kollicoat® Smartseal 100P Using Hot Melt Extrusion Techniques
Favorite
W1130-06-39 - Iodide Assay by Ion Chromatography
Favorite
W1230-06-39 - Isolation of Individual Isomers from Compounds with Multiple Chiral Centers
Favorite
M1430-06-39 - Isolation of Pharmaceutical Degradations using Supercritical Fluid Chromatography (SFC)
Favorite
W1030-06-36 - Isolation, Solid State Characterization and Evaluation of
Digitaria exilis
Starch as Excipient in Formulation
Favorite
M1130-01-01 - IV Infusion In-Use Compatibility of the Regulatory Hormone Melatonin
Favorite
T1130-07-45 - L-cysteine and l-serine Modified Dendrimer with Multiple Reduced Thiols as a Kidney-Targeting Reactive Oxygen Species Scavenger to Prevent Renal Ischemia/Reperfusion Injury
Favorite
T1130-04-24 - Leveraging Amorphous Solid Dispersion Development in an Integrated API to Tablet Pipeline
Favorite
M1430-07-43 - Ligand-Modified Cell Membrane Enables Targeted Delivery of Drug Nanocrystals to Glioma
Favorite
W1230-04-25 - Lipid Architectonics for AIDS Therapeutics and Intervention: Formulation Development and In Vitro Assessment
Favorite
W1030-03-18 - Lipid Nanocapsules for the Encapsulation of Piperine
Favorite
M1130-02-12 - Lipid-Polymer Nanoparticle for Intracellular Staphylococcus Aureus Treatment and Biofilm Eradication
Favorite
T1030-02-11 - Lipiodol-Based Emulsions Used for Drug Delivery in Liver Cancer: Effects of Composition on Stability and Product Quality
Favorite
M1130-03-19 - Liposomes as Carriers for the Delivery of Efavirenz in Combination with Glutathione – A Novel Approach to Combat Opportunistic Infections
Favorite
T1530-02-08 - Liquid Crystals: A Sustained Release Platform for Fenretinide Delivery to Prevent Breast Cancer Development
Favorite
M1430-06-38 - Long Term Stability and Impurities Identification of a Novel Transdermal Formulation for E/Z-Endoxifen
Favorite
T1330-02-09 - Long-Acting Hydrogel Formulation of Novel Bupivacaine Salts for Oral Mucositis Pain Control
Favorite
T1230-02-11 - Long-Term Glycemic Control and Prevention of Diabetes Complications In Vivo Using Oleic Acid-Grafted-Chitosan-Zinc-Insulin Complexes Incorporated in Thermosensitive Copolymer
Favorite
T1530-06-36 - Low-Frequency Raman Mapping and Multivariate Image Analysis for Characterization of Complex Pharmaceuticals
Favorite
T1130-02-14 - Low-in-Nanoparticulate-Impurities Sucrose for Biopharmaceutical Formulations
Favorite
T1330-01-04 - Lyophilized Protein Formulation: Factors Affecting Process Efficiency and Product Quality
Favorite
M1430-04-28 - Mangiferin Loaded Nanocapsules: Preparation and Optimization
Favorite
W1230-04-22 - Mangiferin-Phospholipid-Complex (MPC) in Self-assembled Nanoparticles for the Enhancement of Biopharmaceutical Properties of Mangiferin
Favorite
T1130-03-16 - Matrix Transdermal Patches: Manufacturing When Interchanging Active Pharmaceutical Ingredients
Favorite
W1130-04-23 - Maximizing the Therapeutic Potential of Abiraterone through Bioavailability Enhancement
Favorite
T0930-06-39 - Measuring Moisture Content of Lyophilized Product by Near-Infrared Spectroscopy
Favorite
M1230-01-06 - Mechanistic Characterization and Immunological Profile of Thin Films Suitable for Global Immunization Campaigns
Favorite
T1130-01-03 - Mechanistic Investigation of Accelerated Drug Recrystallization in Amorphous Solid Dispersion Triggered by Magnesium Stearate
Favorite
T1130-04-23 - Mechanochemical Synthesis of a Multicomponent Complex Containing Albendazole and Maleic Acid for Improved Physiochemical Properties
Favorite
T1430-03-16 - Membrane Permeation and Efficacy of Vitamin Nanoemulsions
Favorite
W0930-04-27 - Mesoscopic Confinement of a Crystalline Drug into Micronized Synthetic Silica Gels by Solvent Impregnation Method
Favorite
T1030-06-41 - Method Development for the Dissolution of Spray Dried API Tablets
Favorite
T1030-06-42 - Methods for Dissolution Testing of Surface-Eroding Long-Acting Implantables
Favorite
M1430-05-31 - Methods for the Development of Ivermectin and Praziquantel Granulations with Differing Release Rates
Favorite
T0930-02-09 - Microemulsion Concentration Influences the Mechanical Properties and Drug Release Rate of Ibuprofen In Situ Gels
Favorite
T1430-07-49 - Microfluidic Assembly of Lipid Nanoparticles for the Delivery of Antisense Oligonucleotides to Human Pancreatic Cancer Cells
Favorite
W1130-02-08 - Microfluidic PLGA Nanoformulations in the Prevention and Treatment of Contrast-Induced Nephropathy
Favorite
M1130-06-37 - Micromechanical Thermal Analysis (MTA) to Study Amorphous Relaxations of Small Molecule Drugs
Favorite
T1030-03-18 - Microneedle-Assisted Transdermal Delivery of Optimized Chitosan-Naltrexone Microspheres
Favorite
M0930-03-18 - Microparticles Embedding CaP Nanoparticles for Heart Targeting by Inhalation: Quality by Design Approach for Dry Powder Inhaler Composition
Favorite
W0930-02-11 - Milk Derived Exosomes for Theranostic Applications
Favorite
T1330-07-44 - Miniprintlets: 3D Printed Pellets as a Novel Platform for Multi-drug Therapy
Favorite
T1330-04-23 - Mixed Non-ionic Surfactants Microemulsions with Indomethacin – Structural Studies
Favorite
M1230-06-40 - Mixed-Mode LC-CAD Method Development for the Analysis of Inorganic Ions in Antisense Oligonucleotide (ASO) Drugs
Favorite
T1030-07-46 - Mixture Optimization of Abuse Deterrent Hybrids by Minitab Experimental Design and Analysis
Favorite
M1330-06-38 - Modeling and Prediction of Long-Term Color Change of Tablets Using ASAP and ASAP
prime
® Software
Favorite
M1030-01-01 - Models for Investigating the Effects of Excipients on Drug Transport
Favorite
W1030-07-47 - Modified In Vitro Release Testing (mIVRT) for Testing of Topical Products
Favorite
M1230-06-42 - Modified In Vitro Release Testing Method for Ophthalmic Suspensions Using Franz Diffusion Cell
Favorite
T1230-04-22 - Molar Mass Matters – Impact of Excipient’s Molecular Weight on Dissolution Performance of Amorphous Solid Dispersions
Favorite
T1130-01-06 - Molecular Structure and Interaction of Amorphous Pharmaceuticals using Solid-state NMR Spectroscopy: A Posaconazole Example
Favorite
M1430-04-23 - Molecular Structure Predicts the Tendency of 6 API to Form Amorphous Solid Dispersions Using Melt-Quenching, Rotary-Evaporation, and Spray-Drying
Favorite
M1330-01-07 - More than 20 years on from Sandimmune® and Neoral®: How would we develop a cyclosporine lipid-based formulation using the tools of today?
Favorite
T1330-07-46 - Multifunctional Magnetic Fe
3
O
4
Nanoparticles Coated with Poly(ethylene imine)-Succinic Anhydride Modified with 2,3,5-Triiodobenzoic Acid as CT and MRI Contrast Agents
Favorite
W1230-02-12 - Multifunctional Pathogen-Mimicking Vaccine Delivery System for Influenza Vaccine
Favorite
T1330-02-10 - Naked Poly (Amidoamine) Dendrimers: Anti-Angiogenesis Effects in In-Ovo Chicken Embryo Model
Favorite
M1130-04-27 - Nano Formulation Development using Rotation Revolution Mixer for Toxicological Studies
Favorite
T1330-03-18 - Nanocarrier-Mediated Immunogenic Chemotherapy for Triple Negative Breast Cancer
Favorite
W1230-05-31 - Nanodispersion of Tacrolimus in Rat Pharmacokinetics
Favorite
M1030-01-03 - Nano-in-Micro Powder Technology for the Delivery of Nanoparticles Formulations via the Nose-to-Brain Route
Favorite
M1430-07-45 - Nanoparticle-Mediated Enhanced Delivery of ATRA to Lymph Nodes for Mucosal Vaccination
Favorite
M1330-07-44 - Nanoparticle-Mediated Gene Transfer to the Brain Based on Dual-Functionalized Liposomes
Favorite
T1230-03-19 - Nanoparticles Designed to Deliver Drug(s) across the Blood-Brain Barrier (BBB)
Favorite
T1230-03-17 - Nanoparticles in Smart Hydrogels: A Dual Approach for Targeted Drug Delivery to the Joints
Favorite
W0930-03-16 - Nanosuspension Based Electrolyte Sensitive In Situ Gel for Topical Ocular Delivery of Natamycin
Favorite
W0930-02-12 - Nasal and Intestinal Permeation of Atenolol with Tight Junction Modulator and Fructose Polymer
Favorite
T1530-01-02 - Nateglinide: Three New Polymorphs Discovered by Melt-Crystallization
Favorite
T0930-05-35 - Next Generation of an Oxycodone Immediate Release Product with Abuse Deterrent Features – In Vitro and In Vivo Performance
Favorite
W1230-06-36 - NMR Structure Elucidation and Mechanistic Interpretation of a Novel Rearranged Degradant and Subsequent Use as an Ultra Violet (UV) Relative Response Factor (RRF) Standard
Favorite
W1030-05-35 - Non-destructive Dose Verification of a 3D Printed Anti-hypertensive Polyprintlet
Favorite
M1230-07-43 - Non-destructive Quality Control of 3D Printed Personalized Drug Products for Real-Time Release
Favorite
W1230-01-04 - Non-invasive Three-Dimensional X-Ray Microscopy Imaging Technique for Quantitative Characterization of Lyophilized Drug Product
Favorite
M1530-01-06 - Nose-to-Brain Delivery of Donepezil and Memantine Loaded Liposomes
Favorite
T1530-01-05 - Not Just Polymorphism: The Particle Size as API CQA for Drug Product Development
Favorite
W1130-07-45 - Novel Anti-Counterfeit Measures for 3D Printed Drug Products Using 2D Barcodes and Raman Spectroscopy
Favorite
M1030-03-21 - Novel Application of Hot Melt Extrusion Paired Fused Deposition Modeling 3D Printing Techniques in Fabrication of Ketoprofen Films for Topical Delivery
Favorite
W1030-01-06 - Novel Approaches of Amorphous Solid Dispersion Screening Approaches for APIs with Poor Aqueous Solubility
Favorite
M1230-07-44 - Novel Authentication Technology Using Molecular Tags as a PCID in Solid Oral Dosage Forms
Favorite
M1030-06-36 - Novel Biphasic Lipolysis Testing of Nilotinib Lipid-Based Suspensions to Predict In Vivo Performance
Favorite
T1130-01-07 - Novel Formulation Strategies for Nano-milling in Early Drug Discovery
Favorite
M1230-01-01 - Novel High-Throughput Preformulation Screening Platform for Protein Stability Under Mechanical Stress by Stirring
Favorite
M1030-06-38 - Novel Method for Monitoring of Free Drug Concentration in Presence of Nano-sized Formulations or Dynamically Formed Colloidal Nanoparticles
Favorite
T1230-06-36 - Novel Methodology for Quantitation of Aldehydes in Polyglycols via Oxidation to the Corresponding Carboxylic Acids and Analysis by LC with UV Detection
Favorite
T1330-02-14 - Novel Once-a-Year Controlled Release Capsules for Ruminants
Favorite
M1230-04-25 - Novel Screening Tools for Hot Melt Extrusion: Early Prediction of Formulation Performance
Favorite
M1230-01-03 - Novel Surfactant Excipient Significantly Improves Biologic Stability in Liquid Formulation
Favorite
M1530-06-41 - Nucleic Acid Therapy Purity Methods by Capillary Gel Electrophoresis
Favorite
M1430-06-42 - Observation of API’s Hydration and Dehydration in Formulation Tablets by Frequency- Domain Terahertz Spectroscopy with a High-Peak-Power Tunable Source
Favorite
W1230-05-35 - On-demand 3D Printing of Isoleucine Tablets for the Treatment of MSUD: A Single-Centre, Prospective, Crossover Study
Favorite
T1330-02-08 - On-Demand Versatile Prodrug Nanomicelle for Tumor-Specific Bioimaging and Photothermal-Chemo Synergistic Cancer Therapy
Favorite
T1130-02-12 - One and Two Step IVIVC for Carbamazepine Formulations: Time Scaling through Dissolution Weibull Parameters Scaling
Favorite
M1330-03-19 - Optimization and Characterization of Hot-Melt Extruded Anti-inflammatory and Local Anesthetic Bio-Adhesive Semisolid Formulation Using Design of Experiments (DoE)
Favorite
W0930-07-43 - Optimization of an Evogliptin Active Coating Layer to Prepare Fixed-Dose Combination Tablets for the Treatment of Diabetes
Favorite
T1130-02-10 - Optimization of BCS Class IV Drug Formulation Using Pilot BE Studies Data to Derive In Vivo In Vitro Correlation (IVIVC) Relationship
Favorite
M1530-04-27 - Optimization of BUCHI B-290 Spray-Dryer parameters to enable high-throughput screening of Spray-Dried Solid Dispersions in early stage formulation development.
Favorite
M1030-05-34 - Optimization of Drug X Enteric Coated Mini-tablets Process by Design of Experiment: Influence of Critical Process Parameters (CPP) of GPCG15 on the Physical Characteristics and Release Profile
Favorite
M1330-05-34 - Optimization of Spray-Drying Process Parameters for the Preparation of Levofloxacin/Phytoglycogen/Leucine Dry Powder Inhaler Formulations
Favorite
T1530-01-03 - Optimization of Taste-Masked (-)-Oleocanthal Effervescent Formulation with Potent Activity against HER2-Positive Breast Cancer Growth and Locoregional Recurrence
Favorite
M1530-02-08 - Ovalbumin-Containing Core-Shell Implants Suitable to Obtain a Delayed IgG1 Antibody Response in Mice
Favorite
W1030-02-14 - Overcoming Challenges with Submicron Particle Quantification Using a Combined Approach via Orthogonal Technologies
Favorite
T1230-07-46 - Over-the-Counter (OTC) Male Enhancement Nutraceuticals: Claim, Pharmaceutical Quality, and Safety Assessments
Favorite
T1330-01-06 - Oxaliplatin-Loaded Hydrogel for Prevention of Postoperative Abdominal Adhesion and Colorectal Cancer Therapy
Favorite
T1530-02-11 - Paclitaxel and Letrozole-Loaded Liposomes for the Treatment of Breast Cancer: Formulation Development, Characterization, and Tissue Culture Investigations
Favorite
W0930-03-15 - Paclitaxel Loaded Hydrophobized Gelatin Nanoparticles: Implication of Anacardic Acid Functionalization on Drug Loading and Anti-tumor Efficacy
Favorite
W1230-07-43 - Palatability and Ease of Intake of Fixed-Dose Orally Disintegrating Tablets
Favorite
T1530-05-29 - Patient-Centric Drug Development, Product Design, and Manufacturing: Modular Oral Dosage Forms
Favorite
T1330-03-19 - PEGylated Dendrimer Mediated Delivery of Bortezomib for Improved Anti-cancer Efficacy and In Vivo Pharmacokinetics
Favorite
W0930-06-41 - Performance Evaluation of ASD-Based Tablets: Can Colloid Formation be Modelled?
Favorite
T1330-04-22 - Permeation Enhancement of Transport Media and Their Synergistic Effect with Permeation Enhancer in Nanoemulsions
Favorite
W1130-03-15 - Pharmacokinetic and Pharmacodynamic Evaluation of Multi-Day Topical Application of ∆
9
-Tetrahydrocannabinol-Valine-Hemisuccinate (THC-VHS, NB1111) Nanoemulsion in Normotensive Rabbits
Favorite
T1430-02-13 - Pharmacokinetic and Toxicity Evaluation of Alpinumisoflavone-Loaded Polymeric Micelles
Favorite
W1130-04-25 - Phenylethyl Resorcinol smartLipids – Improved Chemical Stability for Color-Stable Skin Whitening Products
Favorite
T1130-06-41 - Physical and Chemical Stability of Testosterone in Compounded Topical Creams Utilizing a Validated, Stability-Indicating Analytical Method
Favorite
M1530-01-05 - Physical Evaluation of a New Patient-Centered Oral Unit Dosage Form
Favorite
W1230-05-34 - Physical Property Testing of Gelatin and SeaGel® Films for Soft Capsule Applications
Favorite
M1230-02-14 - Physicomechanical Constraints of Components in the Design of Gastroretentive Tablets by Direct Compression
Favorite
M0930-02-09 - Physiologically Based Biopharmaceutics Modeling to Demonstrate Virtual Bioequivalence and Define the Bioequivalence Safe Space: A Case Study
Favorite
M1130-05-30 - Physio-Mechanical Properties of Ultrafine Particle Size Low Molecular Weight Hydroxypropylcellulose: Effect of Binder Particle Size on Tablet Performance
Favorite
M1130-01-05 - Pitfalls and Challenges of Analyzing Particle Size Distribution in Ophthalmic Suspensions Using Laser Diffraction
Favorite
T1430-05-34 - Plasdone
TM
Copovidone Ultra S-630 for Oxidation-Labile Drugs
Favorite
M0930-02-11 - PLGA Based Drug Delivery and Importance of In Vitro Release Determination and Experimental Insights: Development of a Novel “Basket-in-Tube” Method
Favorite
M1530-02-10 - Poly(lactic-co-glycolic) Acid Implants for Local Controlled Release of Monoclonal Antibodies, CpG ODN, and Docetaxel
Favorite
M1330-03-17 - Poly(Lactide-co-Glycolide) Based in Situ Film-Forming System for Topical Delivery of Trolamine Salicylate
Favorite
W1130-05-30 - Poly(meth)Acrylate Polymers in FDM 3D Printing as a Platform for Designing Tailored Release Profiles
Favorite
M1530-02-12 - Polyester Dendrimer-Platinum Nanochemotherapeutics: Synthesis and Efficacy in 2D and 3D Lung Cancer In Vitro Models
Favorite
W1130-05-34 - Polymer Influence on the Rheological Properties of Colloidal Microcrystalline Cellulose
Favorite
M1030-02-13 - Polymeric Lipids Nanoparticles: New Approach Utilizing Vitamin E-TPGS And PLGA for Treating Colorectal Cancer
Favorite
T1530-03-20 - Polymeric Nanosystem for Treatment of Ewing’s Sarcoma
Favorite
T1230-01-04 - Polysorbate Degradation in Biologics Formulations and the Formation of FFA Particles
Favorite
T1330-05-33 - Polyvinyl Alcohol (PVA) for Tablet Coating Applications: Enhancing Formulation Flexibility
Favorite
M1030-04-23 - Polyvinyl Alcohol Gel for Topical Delivery of Kinetin
Favorite
T1030-02-09 - Porous 3D Printed 316L Metal Implants Coated with Dexamethasone for Sustained Drug Delivery
Favorite
T0930-04-28 - Posaconazole Cocrystal with Superior Solubility and Dissolution Behavior
Favorite
T1330-07-47 - Positron Emission Tomography-Guided Targeting of Pathogenic
E. coli
Infections
Favorite
W1130-06-41 - Powerful Combination between AQbD and High-Throughput Analytical Toolkit to Support an Efficient RP-LC Method Development
Favorite
T1430-02-10 - Predicting Density of Amorphous Solid Materials using Molecular Dynamics Simulation
Favorite
T1530-04-23 - Predicting Solid Dispersion Stability Using Multiple Linear Regression Models
Favorite
M1530-04-28 - Predicting the Physical Stability of Amorphous Solid Dispersions: Understanding the Impact of Material Properties
Favorite
M0930-02-10 - Prediction of Fraction of Dose Absorbed Based on In Vitro Solubility and Flux Measurements
Favorite
T1130-02-09 - Prediction of Maximum Absorbable Dose and Fraction Absorbed based on
In Vitro
Flux Measurements
Favorite
T1030-01-07 - Prediction of Peptide Aggregation Propensities
Favorite
W1030-02-08 - Prediction of the Effect of Co-administration of Food with Granules in Adults and Infants Based on Biorelevant Dissolution Testing
Favorite
W0930-06-38 - Predictive In Vitro Drug Release Testing of Vaginal Dosage Forms - A Novel Method for Establishing an
IVIVR
for Contraceptive Intravaginal Rings
Favorite
W1030-03-17 - Preparation and Characterization of Hydrophilic Polymer-Lipid Complexes of Phytochemicals Combinations
Favorite
T1430-04-23 - Preparation and Characterization of Lercanidipine Nanoparticles Using High Pressure Homogenizer
Favorite
T1030-04-22 - Preparation and Characterization of Lutein Loaded Nanoparticles Using PLGA-PEG-FOL Polymer
Favorite
W1030-05-33 - Preparation and Optimization of Enteric-Coated Tablet System for Delayed-Release and Solubilization of Bisacodyl
Favorite
T1130-07-43 - Preparation of Triple-Layered Films Using 3D Printing Technology
Favorite
W1230-07-48 - Preparation, Characterization and Performance of Polymeric Particles Encapsulating a Highly Soluble Drug Using Both Batch and Microfluidic Techniques
Favorite
M0930-02-13 - Preparation, Characterization and Pharmacokinetic Study of Donepezil-Loaded PLGA Microparticles Injected in Beagle Model
Favorite
T0930-01-01 - Preparation, Characterization, and Aerosol Performance Testing of Engineered Spray Dried Tobramycin Dry Powder Aerosol Formulations
Favorite
T1430-04-22 - Preparation, Characterization, and Optimization of Pirfenidone-Loaded Polymeric Nanoparticles
Favorite
M1530-04-24 - Preparation, Solid-State Characterization, and Solubility Assessment of Dronedarone HCl-Naringin Co-amorphous Systems
Favorite
W1230-02-10 - Preparation and Evaluation of Transferrin Conjugated Nanostructured Lipid Carriers for Targeting Artemisone to Melanoma Cells
Favorite
W1030-03-20 - Prepartion and Characterization of Gentamicin Sulfate Loaded Inhalable Magnetic Nanoparticles
Favorite
T1530-04-27 - Preventing Crystallization and Improving Dissolution of Delamanid by In Situ Formation of Amorphous Solid Dispersions of Sulfonate Salts
Favorite
T1230-02-14 - Printing Biopharmaceuticals onto Orodispersible Films
Favorite
M0930-06-37 - Product Characterization and Development of In Vitro Drug Release Assay of Exparel® Bupivacaine Multivesicular Liposomes
Favorite
M1230-02-09 - Production of Lysozyme-PLGA Particles for Extended Release Using Hot Melt Extrusion Technology
Favorite
T1030-01-02 - Promoting Intracellular Cholesterol Efflux to Recombinant High-Density Lipoproteins by Cyclodextrins
Favorite
M1030-07-49 - Prospects of Chewable Tablets of Chewing Sticks as an Alternative to Conventional Toothpaste
Favorite
T1230-01-03 - Protection of Proteins from Proteolysis by Lipophilic Complexation
Favorite
W1230-07-45 - Protein Kinase C Inhibitor Anchored BRD4 PROTAC PEGylated Nanoliposomes for the Treatment of BRAFV600E Mutated Vemurafenib-Resistant Melanoma
Favorite
M0930-07-48 - Proteolysis-Targeting Chimeric (PROTAC) Targeting BRD4 Protein: A Novel Potential Therapy for Pancreatic Ductal Adenocarcinoma
Favorite
T1130-05-29 - PVA-Based Sustained Release Matrix Tablets – Roller Compaction vs Direct Compression
Favorite
M1230-05-35 - QbD Approach for Understanding the Effects of Formulation and Process Variables on the Printlets Quality Manufactured by SLS 3D Printing
Favorite
M1530-06-38 - Quality Considerations of the 3D Printable Filaments Manufactured by Continuous Melt Extrusion I: Mechanical Properties Analysis
Favorite
M0930-06-38 - Quality Considerations of the 3D Printed Oral Pharmaceutical Products I: The Effect of Tablet Designs
Favorite
M1530-01-02 - Quality Evaluation of Brand and Generic Extended Release Phenytoin Sodium Capsules
Favorite
T0930-04-26 - Quality-by-Design Guided Engineering of Inhalable Co-amorphous of Itraconazole with Succinic Acid via Spray Drying
Favorite
M1030-06-42 - Quantitative Analysis of Total siRNA in siRNA-Polymeric Nanoparticle Formulation by AEX-HPLC
Favorite
M1130-06-36 - Quantitative Characterization of Crystalline Content in Amorphous Solid Dispersion Formulations Using X-Ray Microscopy
Favorite
T1230-06-42 - Quantitative Comparison of Peptide Impurities in Teriparatide from Biological and Synthetic Origins Using UPLC-MS/MS
Favorite
T1130-05-35 - Quick-Set, High-Solids Pharmaceutical Tablet Coatings
Favorite
T1230-04-28 - Rapid Transition of a Novel Celecoxib Formulation from a Fit-for-Phase Presentation to a Commercializable Product Using an Innovative Integrated Drug Development and Clinical Testing Platform
Favorite
M1330-06-39 - Rapid UPLC-MS/MS Method for Simultaneous Quantification of Kratom Alkaloids in
Mitragyna speciosa
Products
Favorite
W1130-01-03 - Rational Design and Development of Perfluorocarbon-Based Oxygen Carriers for Organ Preservation
Favorite
M1330-01-01 - Rational Formulation of Ciprofloxacin-Chitosan Nanoplexes for Enhanced In Vitro Drug Release and Extended Synergistic Antimicrobial Potency
Favorite
T1330-01-03 - Ready-to-Use Injectable Formulations Using New Tri-block Copolymers for Anticancer Drug Delivery
Favorite
T1030-07-49 - Release Time and Rate Control Using 3D-Printing Technologies and Evaluation of a Novel Chronotherapeutic Drug Delivery System
Favorite
T1430-03-19 - Remodeling-Tuned Lipoprotein Nanoparticulates Templated for Multidrug Shielding on Sustainable and Combination Therapy of Alzheimer's Disease
Favorite
T1230-07-45 - Repaglinide-Loaded Solid Lipid Nanoparticles for Oral Delivery of Anti-Diabetes Treatment Prepared by Spray Drying and Microfluidization
Favorite
T1330-02-11 - Repurposing an Antimalarial Drug for Efficacy in Diverse Breast Cancer Subtypes
Favorite
T1030-03-20 - Repurposing Artesunate, an Anti-malarial Drug, as an Inhaled Formulation for the Treatment of Pulmonary Arterial Hypertension
Favorite
T0930-06-38 - Residual Solvent Variations in Transdermal Drug Delivery Systems
Favorite
W0930-01-02 - Resveratrol-Loaded Ethosomal In Situ Nasal Gel Drug Delivery: A Novel Approach for Brain Targeting in Glioblastoma
Favorite
M1530-03-19 - Retinoid Containing Face Wash Lotion for the Treatment of Acne [DRL Publication No. 878]
Favorite
W1230-04-24 - Revaprazan-Loaded Surface-Modified Solid Dispersion: Physicochemical Characterization and In Vivo Evaluation in Rats
Favorite
M1130-03-21 - Review of Advanced Analytical Methods in Complex Polymeric Drug Substance Characterization
Favorite
W1030-07-46 - Rheological Characterization of Topical Pharmaceutical Foam Products
Favorite
T1230-05-34 - Rheology Guided Drug Load Optimization in a Plasdone
TM
S630 Ultra (Copovidone)/Nifedipine System
Favorite
W1230-07-46 - Rigid Structure Polymers for the Development of Safe and Effective Opioid Drug Formulations
Favorite
T1530-01-06 - Rilpivirine-Associated Aggregation Induced Emission Enables Cell-Based Nanoparticle Tracking
Favorite
T1430-07-44 - RNA Nanoparticles Cooperated with Exosome as Efficient In Vivo RNAi Delivery for Cancer Treatment
Favorite
W1230-03-21 - Root Cause Analysis and Characterization of Foreign Particulate in Parenteral Products Using Multiple Complementary Analytical Techniques
Favorite
M1530-06-37 - RP-HPLC Method Development, Validation, and Determination of Letrozole and Paclitaxel Combination in a Nanoliposome Formulation
Favorite
W1230-07-47 - Safe, Swallowable and Palatable Pediatric Mini-tablet Formulations for a Compound from the WHO Model List of Essential Medicines for Children – Formulation Development and In Vitro Characterization
Favorite
T1530-01-01 - Scalable Manufacturing of Liposomes to Improve Therapeutic Efficacy by Encapsulation of Drugs Using High Pressure Microfluidizer
Favorite
T1230-04-25 - Scaled-Up Production of Lumefantrine Nanoparticles
Favorite
T1130-07-47 - Scientific Networks: Beyond Scientists Engagement, a Hub of Innovation to Boost Operational Excellence
Favorite
T1430-07-48 - Selection of the Suitable Amount of Benzydamine to be Used in a Fixed Combination with Econazole for the Development of a New Vaginal Pessary Formulation
Favorite
M0930-04-28 - Selective Salt and Co-Crystal Generation Using Green Chemomechanical Technology
Favorite
T1030-01-01 - Self-Assembled Biotinylated Nanomicelles Loaded Celecoxib for AMD
Favorite
T0930-07-46 - Self-assembling Lisofylline-Fatty Acid Conjugate for Effective Treatment of Diabetes Mellitus
Favorite
M1330-07-46 - Sensory Evaluation of Norvir® (Ritonavir) 100 mg Powder for Special Populations
Favorite
T1330-07-45 - Shape Memory Expandable Gastroretentive Drug Delivery System Manufactured by 4D Printing
Favorite
W0930-01-07 - Shear Rate Dependent Viscosity as an Indicator of Protein-Protein Interactions and Cluster Formation
Favorite
W1230-05-33 - Silicified Microcrystalline Cellulose for Improving Disintegration Time in Oro-Dispersible Tablets
Favorite
T1530-06-41 - Simplifying Workflows for MAM-Based Critical Quality Attribute Monitoring of Biotherapeutics in Process Development and QC Using a Novel LCMS Platform
Favorite
W0930-04-28 - Simultaneous Improvement of Aqueous Solubility and Tabletability of Theophylline with Cocrystallization
Favorite
T0930-06-37 - Simultaneous UPLC-ESI-MS/MS Analysis of Fourteen Components Including Metabolites of Gumiganghwal-Tang Tablet in Human Plasma: Application to Pharmacokinetic Study
Favorite
M0930-03-17 - Skin Follicular Targeting in Acne Treatment: Potentials with Isotretinoin-Loaded Delonix Nanoparticles
Favorite
M1530-03-16 - Skin Microporation and Iontophoresis for the Rapid Delivery of Ketamine for Treatment-Resistant Depression
Favorite
M1230-04-28 - Small Molecule Nanosuspension Formulation Development Using a Resonant Acoustic Mixer
Favorite
M1130-04-23 - Sodium Oleate-Based Solid Lipid Nanoparticles to Enhance Oral Bioavailability of Oleanolic Acid
Favorite
W1030-04-22 - Solid Self-nanoemulsifying Drug Delivery System (SNEDDS) for Improved Oral Bioavailability of Water-Insoluble Rivaroxaban
Favorite
W1030-01-05 - Solid-State Properties and Manufacturability of Two Celecoxib N-Methyl-2-Pyrrolidone Solvates
Favorite
W1130-07-48 - Solubility Enhancement of Drugs for Colonic Applications Using EUDRAGIT
®
FS 100
Favorite
M1130-01-02 - Solubilization of an Insoluble Neural Vasodilator Using a Nanomicelles Drug Delivery System in the Treatment of Subarachnoid Hemorrhage
Favorite
W0930-05-29 - Source Variation of Outer Membranes on Drug Release from Intrauterine Systems
Favorite
M1030-07-43 - Spray Freeze Dried Inhalable Liposomal Powder Formulations for Co-delivery of Synergistic Ciprofloxacin and Colistin Against Multi-drug Resistant Gram-Negative Lung Infections
Favorite
M0930-07-45 - Spray-Dried Engineering of Long-Acting Controlled Release Poly (Lactic-co-Glycolic Acid) Microspheres Loaded with Luteinizing Hormone-Releasing Hormone Agonist (LHRHa)
Favorite
M0930-01-06 - Spray-Drying Versus Spray Freeze-Drying Technique for the Formulation of Inhalable Sildenafil-Citrate Dry Powder
Favorite
M1130-05-31 - Stability of Non-Synthetic Pigments in Fully Formulated Film Coating Systems
Favorite
T1530-07-44 - Stability Studies of Anti-VEGF FpFs Obtained from Bevacizumab Digested with Different Enzymes
Favorite
T1530-04-22 - Stable Amorphous Solid Dispersion Formation is Not Predicted Exclusively by Drug-Polymer Miscibility
Favorite
T1530-01-04 - Standardized and Bias-Corrected Density Functional Theory in the Estimation of X-H Bond Dissociation Energy – Potential Tool in Predicting Oxidative Decomposition of Pharmaceuticals
Favorite
M1130-03-20 - Strategic Analysis of the Roadmap for Implementing Characterization-Based Bioequivalence Approaches in Product-Specific Guidances for Generic Topical Dermatological Drug Products
Favorite
W0930-04-22 - Structure of Molecular Glasses by Synchrotron X-ray Total Scattering
Favorite
T1430-04-28 - Structured Development Approach for Formation of Apremilast Amorphous System and Design of a Controlled Release Drug Delivery System
Favorite
T1130-01-02 - Studies of Solubility and Formulation Methods of Cannabinoid CB
1
Receptor Allosteric Modulator ZCZ011
Favorite
M1230-07-48 - Studies on the Role of Antioxidants in Impurity Profile Control of Rifapentine Tablets
Favorite
T0930-05-33 - Study of the Impact of Wet Granulation Process Parameters on Granule Properties and Compression Characteristics of Poorly Soluble Drug
Favorite
T1230-01-05 - Studying Vesicles Membrane Stability of Nanotransfersomes Containing Bile Salts Using Calcein as a Marker for Stability
Favorite
T1530-06-37 - Submicron Protein Aggregation Measurements for Early Assessment of Formulation Instability
Favorite
M1430-02-10 - Supersaturated Silica-Lipid Hybrid (super-SLH) Oral Drug Delivery Systems: Balancing Drug Loading and In Vivo Performance
Favorite
M1330-04-26 - Surface Characterization as a Tool for Identifying the Factors Affecting the Dissolution Rate of Amorphous Solid Dispersions
Favorite
M1130-01-06 - Surface Properties of Doxil-Mimicking Liposomes: Effect of Composition and Particle Size
Favorite
M1330-04-27 - Surface-Eroding Elastomer Exhibits Zero-Order Release in Highly Loaded LAIs
Favorite
T0930-04-25 - Surfactants as Stabilizers of the Colloidal Phase Formed Upon Amorphous Solid Dispersion Dissolution
Favorite
M1330-03-16 - Susceptibility to Particulate Formation in Parenteral Solutions - A Case Study
Favorite
T1530-07-45 - Sustained Release Floating Tablets Prepared by Fusion Deposition Modeling 3D Printing
Favorite
M1130-02-11 - Sustained-Released Formulation of Nifedipine Solid Dispersion with Various Polymers
Favorite
M1030-05-29 - Synchronized Drug and Polymer Release from Injection Moulded Controlled Release Amorphous Solid Dispersion Tablets
Favorite
M1130-06-39 - Synchrotron X-Ray Diffraction and Pair Distribution Function Analysis of Drug/Polymer Dispersions: A Comparison of Subtraction Techniques to Isolate Intra- and Intermolecular Interactions
Favorite
M0930-03-16 - Synergistic Combination of Novel Tubulin Inhibitor and Dual PI3K/AKT/mTOR-BRD4 Inhibitor to Treat Pancreatic Cancer
Favorite
W1230-03-19 - Synergistic Photothermal/Immunotherapy Modulating Immune Tumor Microenvironment by Core-Shell Gel Microneedles for Melanoma Therapy
Favorite
M1030-03-19 - Synthesis and Characterization of Temozolomide Loaded Albumin Gel as Implantable Formulation for Glioblastoma Treatment
Favorite
T1530-05-33 - Synthesis and Computational Modelling to Predict Loading of 5-fluorouracil into Mesoporous Silica Nanoparticles for the Treatment of Colorectal Cancer
Favorite
M1430-02-08 - Synthetic High-Density Lipoprotein Nanodiscs for Personalized Vaccination against Glioblastoma Multiforme
Favorite
M1430-02-14 - Systematic Development and Optimization of Pirfenidone Liposomes for Non-Small Cell Lung Cancer Treatment
Favorite
W0930-05-31 - Tablet Coatings for Taste-Masking – Efficiency In Vivo
Favorite
M0930-04-27 - Tablet Formulation Development of Amorphous Solid Dispersions with StarTab™ Directly Compressible Starch as Filler
Favorite
T0930-01-06 - Tablet Splitting of Polymeric Matrices
Favorite
M1230-05-34 - Tableting Properties of Direct Compressible Excipients with Different Manufacturing in High-Speed Direct Compression
Favorite
T1030-02-12 - Tacrolimus Nanomicellar Eye Drops as a Topical Treatment for Diabetic Retinopathy
Favorite
T1530-03-18 - Targeted Immunotherapy System using Novel Nanoparticles: Feasibility for Selective Delivery
Favorite
W0930-07-44 - Targeted Knockdown of Pro-inflammatory Cytokines in Adipose Tissue Macrophages and Adipocytes for the Treatment of Insulin Resistance
Favorite
T1530-03-15 - Targeting Specific Immune Cells by Fine Tuning the Physicochemical Properties of Polymeric Nanoparticles
Favorite
W1030-05-30 - Taste Masking Bitter Drugs with Ion Exchange Resin in Carrageenan Based Gummies
Favorite
T1030-03-16 - Taste Masking of Clarithromycin through Microencapsulation in Eugdragit S by Solvent Evaporation Method
Favorite
T1030-05-29 - Taste-Masked Azithromycin Dry Syrup for Pediatric Use Based on EUDRAGIT
®
E PO
Favorite
T1030-05-30 - Taste-Masking Effects of Guaifenesin Coated Particles Dependent on Coating Weight Using Hypromellose Phthalate
Favorite
M1030-01-02 - Terconazole Bile Based Nanovesicles: A Novel Platform for Augmented Ocular Delivery
Favorite
W0930-07-47 - Ternary Inclusion Complex of Ebselen with Cyclodextrin Polymer and Soluplus: Targeting Vaginal Candidiasis and Pre-exposure Prophylactic for HIV
Favorite
M1430-01-06 - Texture Analyzer as a CQA Tool to Evaluate Sensorial Properties like Hardness, Adhesiveness, Cohesiveness, Tackiness, Spreadability and Consistency for Topical Ointment Formulation
Favorite
M0930-01-04 - The Aerosol Performance of TNF-α siRNA Solid Lipid Nanoparticles for Potential Pulmonary Delivery
Favorite
W1230-06-42 - The Cloak of Invisibility for Subvisible Particles: Evaluating the Impact of Refractive Index and Color on Measured Particle Count by HIAC and MFI
Favorite
T1130-03-20 - The Correlation of Rheological Behavior and In Vitro Release Rate for 811 Cream
Favorite
W0930-02-13 - The Development of the Hydrogel Based on Sodium Hyaluronate Containing Granisetron
Favorite
M1130-07-46 - The Ease of Orally Taking Mini-tablets Containing a Large Amount of Drug
Favorite